> Per capita comparisons are interesting, as they represent
> efforts, within political boundaries, equally.
> Data is easily obtained by visiting the data explorer page
> at Our World in Data:

> http://tiny.cc/ul41tz

>
> A 100ppm daily detection rate would, in one year, result in
> an approximately 4% penetration within the population.
>
> Testing of blood donor samples in Quebec suggests that covid-19
> antibodies are present in the local population at 3x positive
> virus detection test rate.
>
> Median age in Germany and Italy is 45-46yrs.
> Median age in Canada, UK and Sweden is 40-41yrs.
> Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively.
> Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
> Median age in Israel is 30.4yrs.
> Median age in Peru and Mexico is 27.5yrs.
> Median age in India is 26.8yrs.
> Median age in South Africa is 25yrs.
>
>
Comparison charts, as of Apr 30 are available:
http://ve3ute.ca/query/210430_cases_ppm_major.jpg
http://ve3ute.ca/query/210430_cases_ppm_report_group.jpg
http://ve3ute.ca/query/210430_deaths_daily_ppm_report_group.jpg
http://ve3ute.ca/query/210430_deaths_ppm_report_group.jpg
http://ve3ute.ca/query/210430_vaccinations_report_group.jpg
http://ve3ute.ca/query/210430_vaccinations_major.jpg
>
>
>
Flu Season? Fatality comparison in the U.S.A.
http://ve3ute.ca/query/flu_season_020.jpg
Updated Apr30
>

> Israel, with >120% of vaccine doses applied to vaccinate 58% of
> the population, reports a daily virus detection rate below 15ppm
> and a 0.2ppm/day fatality rate. These figures have not altered
> significantly in the last 30 days - indicating the end of
> Pfizer's vaccination trial.

> The US, UK and Chile have all issued >70% of vaccine doses, with
> vaccination rates of 29%, 21% and 34% respectively. Detection
> rates have stabilized in all three nations, but at levels that
> do not correlate to one another.

As of Apr29:
US detections are at 97950ppm.(9.8%)
Detection rate is 149ppm/day and falling.
Fatalities are 1743ppm at 2.0ppm/day
FR is 1.8% from a 97207ppm detection recorded 7 days previously.
US tests total 1249240ppm (125%) at 2790ppm/day
7.8% of tests are positive - currently 5.3%.
Vaccinations at 734300ppm (73.4%) with 31.3% vaccinated.

Canada detections at 32878ppm (3.3%) ~ 170 days behind the US.
Detection rate at 204ppm/day and falling.
Fatalities are 643ppm at 1.2ppm/day.
FR is 2.0% from a 31865ppm detection recorded 7 days previously.
Canada tests total 829980ppm (83%) at 3430ppm/day
4.0% of tests are positive - currently at 5.9%.
Vaccinations at 36630ppm (36.6%) with 3.0% vaccinated.

Italian detections at 66898ppm. (6.7%)
Detection rate is 194ppm/day and falling.
Fatalities are 2004ppm at 4.6ppm/day.
FR is 3.0% from a 65852ppm detection recorded 7 days previously.
Italian tests total 963270ppm (96%) - at 4700ppm/day.
6.9% of tests are positive - currently 4.1%.
Vaccinations at 313300ppm (31.3%) with 10.3% vaccinated.

Sweden detections at 96403ppm. (9.6%)
Detection rate is 499ppm/day and falling.
Fatalities are 1391ppm at 1.8ppm/day.
FR is 1.5% from a 94388ppm detection recorded 7 days previously.
Sweden tests performed are unreported at 4620ppm/day
No test positivity rate is possible - currently 10.8%
Vaccinations at 323500ppm (32.4%) with 7.5% vaccinated.

UK detections at 65342ppm. (6.5%)
Detection rate is 32ppm/day and leveling below 40ppm/day.
Fatalities are 1883ppm at 0.2ppm/day.
FR is 2.9% from a 65187ppm detection recorded 7 days previously.
UK tests total 2231930ppm (223%) at 15930ppm/day.
2.9% of tests are positive - currently 0.2%.
Vaccinations at 734100ppm (73.4%) with 22.6% vaccinated

Brazil detections at 694156ppm. (6.9%)
Detection rate is 278ppm/day and falling.
Fatalities are 1918ppm at 11.3ppm/day.
FR is 2.8% from a 67941ppm detection recorded 7 days previously.
Brazil tests performed are unreported.
No test positivity rate is possible.
Vaccinations at 203100ppm (20.3%) with 6.5% vaccinated.

Peru detections at 54926ppm (5.5%)
Detection rate is 214ppm/day and falling.
Fatalities are 1884ppm at 10.4ppm/day.
FR is 3.5% from a 53627ppm detection recorded 7 days previously.
Peru tests performed are unreported.
No test positivity rate is possible.
Vaccinations at 50400ppm (5.0%) with 1.9% vaccinated

Chile detections at 63345ppm (6.3%)
Detection rate is 309ppm/day and falling.
Fatalities are 1389ppm at 5.3ppm/day.
FR is 2.3% from a 59436ppm detection recorded 14 days previously.
Chile tests performed 679000ppm (68%) - at 3030ppm/day.
9.3% of tests are positive - currently 10.2%.
Vaccinations at 776700ppm (77.7%) with 35.2% vaccinated.

Argentina detections at 66494ppm (6.6%)
Detection rate is 456ppm/day and falling.
Fatalities are 1422ppm at 8.2ppm/day.
FR is 2.2% from a 64280ppm detection recorded 7 days previously.
Argentina tests performed total 189480ppm (19%) at 850ppm/day.
34% of tests are positive - currently 54%.
Vaccinations at 177000ppm (17.7%) with 2.2% vaccinated.

Mexico detections at 18218ppm (1.8%)
Detection rate is 23ppm/day and possibly leveling below 30ppm/day.
Fatalities are 1685ppm at 2.5ppm/day.
FR is 9.3% from a 18096ppm detection recorded 7 days previously.
Mexico tests performed total 47920ppm (4.8%), at 100ppm/day.
39% of tests are positive - currently 23%.
Vaccinations at 142100ppm (14.2%) with 5.9% vaccinated.

South Africa detections at 26709ppm (2.7%)
Detection rate is 21ppm/day and possibly leveling at 20ppm/day.
Fatalities are 918ppm at 0.7ppm/day.
FR is 3.5% from a 26593ppm detection recorded 7 days previously.
SA tests performed total 179150ppm (17.9%) at 430ppm/day.
14.9% of tests are positive - currently 4.6%.
Vaccinations at 5400ppm (~0.5%) with ~0.5% vaccinated.

Czech detections at 152593ppm (15.3%)
Detection rate is 197ppm/day and falling.
Fatalities are 2740ppm at 5.1ppm/day.
FR is 1.8% from a 151534ppm detection recorded 7 days previously.
Czech tests are unreported (~65%), at 14600ppm/day.
No test positivity rate is possible - currently 1.3%.
Vaccinations at 299000ppm (29.9%) with 9.5% vaccinated.

India detections at 14439ppm (1.4%)
Detection rate is 270ppm/day and rising to levels not seen previously.
Fatalities at 159ppm at 2.5ppm/day.
FR is 1.2% from a 13041ppm detection recorded 7 days previously.
Indian tests performed total 207530ppm (21%) at 1240ppm/day.
7.0% of tests are positive - currently 21.8%.
Vaccinations at 111700ppm (11.2%) with 2.0% vaccinated.

Isreal detections at 96881ppm (9.7%)
Detection rate is 9ppm/day and leveling below 10ppm/day
Fatalities at 735ppm at 0.2ppm/day.
FR is from a 96842ppm detection recorded 7 days previously.
Israeli tests performed total 1860260ppm (186%) at 3650ppm/day.
5.2% of tests are positive - currently 0.2%
Vaccinations at 1208300ppm (121%) with 58.4% vaccinated.

>
> Chile participated in Phase 3 trials for AstraZeneca,
> Johnson & Johnson, Sinovac and CanSino. Chile has contracts
> with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
> Sinovac is their regular supplier of seasonal flu vaccine.
> Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
> temperatures. About 60% of Chile's contracted 80 million doses
> are from Sinovac.
>
> Chile maintains a Public Health service database that includes
> regular vaccination scheduling. Using these resources alone
> allowed vaccination rates as high as 1 million doses per week
> to be delivered as early as mid-February. Approval of vaccine
> use was based on published Phase 1 and Phase 2 reporting.
>
> multiply ppm by population (in millions) for real numbers.
> China - 1397 million
> Iceland - 0.36 million
> US - 330 million
> Canada - 37 million
> Italy - 60 million
> Sweden - 10 million
> UK - 66 million
> Brazil - 210 million
> Peru - 32 million
> Chile - 19 million
> Argentina - 45 million
> Mexico - 127 million
> South Africa - 58 million
> Czech Republic - 10.7 million
> Israel - 10 million
> India - 1391 million

RL

Last posting should have been dated May03. (~ other typos)

> Per capita comparisons are interesting, as they represent
> efforts, within political boundaries, equally.
> Data is easily obtained by visiting the data explorer page
> at Our World in Data:

> http://tiny.cc/ul41tz

>
> A 100ppm daily detection rate would, in one year, result in
> an approximately 4% penetration within the population.
>
> Testing of blood donor samples in Quebec suggests that covid-19
> antibodies are present in the local population at 3x positive
> virus detection test rate.
>
> Median age in Germany and Italy is 45-46yrs.
> Median age in Canada, UK and Sweden is 40-41yrs.
> Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively.
> Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
> Median age in Israel is 30.4yrs.
> Median age in Peru and Mexico is 27.5yrs.
> Median age in India is 26.8yrs.
> Median age in South Africa is 25yrs.
>
>
> Comparison charts, as of Apr 30 are available:
> http://ve3ute.ca/query/210430_cases_ppm_major.jpg
> http://ve3ute.ca/query/210430_cases_ppm_report_group.jpg
> http://ve3ute.ca/query/210430_deaths_daily_ppm_report_group.jpg
> http://ve3ute.ca/query/210430_deaths_ppm_report_group.jpg
> http://ve3ute.ca/query/210430_vaccinations_report_group.jpg
> http://ve3ute.ca/query/210430_vaccinations_major.jpg
>
>
>
> Flu Season? Fatality comparison in the U.S.A.
> http://ve3ute.ca/query/flu_season_020.jpg
> Updated Apr30
>

> Israel, with >120% of vaccine doses applied to vaccinate 58% of
> the population, reports a daily virus detection rate below 15ppm
> and a 0.2ppm/day fatality rate. These figures have not altered
> significantly in the last 30 days - indicating the end of
> Pfizer's vaccination trial.

> The US, UK and Chile have all issued >70% of vaccine doses, with
> vaccination rates of 29%, 21% and 34% respectively. Detection
> rates have stabilized in all three nations, but at levels that
> do not correlate to one another.

As of May07:
US detections are at 98503ppm.(9.9%)
Detection rate is 136ppm/day and falling.
Fatalities are 1752ppm at 2.0ppm/day
FR is 1.8% from a 97724ppm detection recorded 7 days previously.
US tests are unreported (~125%) at ~2890ppm/day
No test positivity rate is possible - currently ~4.7%.
Vaccinations at 753400ppm (75.3%) with 32.6% vaccinated.

Canada detections at 33761ppm (3.4%) ~ 172 days behind the US.
Detection rate at 205ppm/day and possibly leveling at ~210ppm/day.
Fatalities are 649ppm at 1.2ppm/day.
FR is 2.0% from a 32546ppm detection recorded 7 days previously.
Canada tests total 845150ppm (85%) at 3550ppm/day
4.0% of tests are positive - currently at 5.8%.
Vaccinations at 395400ppm (39.5%) with 3.2% vaccinated.

Italian detections at 67517ppm. (6.8%)
Detection rate is 172ppm/day and falling.
Fatalities are 2022ppm at 4.0ppm/day.
FR is 3.0% from a 66532ppm detection recorded 7 days previously.
Italian tests total 979740ppm (98%) - at 4640ppm/day.
6.9% of tests are positive - currently 3.7%.
Vaccinations at 374500ppm (37.5%) with 11.4% vaccinated.

Sweden detections at 99227ppm. (9.9%)
Detection rate is 487ppm/day and falling.
Fatalities are 1407ppm at 2.2ppm/day.
FR is 1.5% from a 96403ppm detection recorded 7 days previously.
Sweden tests performed are unreported at ~4620ppm/day
No test positivity rate is possible - currently 10.5%
Vaccinations at 352900ppm (35.3%) with 7.9% vaccinated.

UK detections at 65467ppm. (6.5%)
Detection rate is 30ppm/day and leveling below 40ppm/day.
Fatalities are 1883ppm at 0.2ppm/day.
FR is 2.9% from a 65290ppm detection recorded 7 days previously.
UK tests total 2250000ppm (225%) at 15810ppm/day.
2.9% of tests are positive - currently 0.2%.
Vaccinations at 754600ppm (75.5%) with 24.0% vaccinated

Brazil detections at 70585ppm. (7.1%)
Detection rate is 277ppm/day and falling.
Fatalities are 1962ppm at 10.6ppm/day.
FR is 2.8% from a 68964ppm detection recorded 7 days previously.
Brazil tests performed are unreported.
No test positivity rate is possible.
Vaccinations at 219000ppm (21.9%) with 7.1% vaccinated.

Peru detections at 55344ppm (5.5%)
Detection rate is 178ppm/day and falling.
Fatalities are 1910ppm at 9.7ppm/day.
FR is 3.5% from a 54575ppm detection recorded 7 days previously.
Peru tests performed are unreported.
No test positivity rate is possible.
Vaccinations at 57500ppm (5.8%) with 2.0% vaccinated

Chile detections at 64304ppm (6.4%)
Detection rate is 286ppm/day and falling.
Fatalities are 1407ppm at 4.8ppm/day.
FR is 2.3% from a 60467ppm detection recorded 14 days previously.
Chile tests performed 692790ppm (69%) - at 2970ppm/day.
9.3% of tests are positive - currently 9.6%.
Vaccinations at 800200ppm (80.0%) with 36.6% vaccinated.

Argentina detections at 68493ppm (6.8%)
Detection rate is 445ppm/day and falling.
Fatalities are 1466ppm at 8.7ppm/day.
FR is 2.2% from a 65877ppm detection recorded 7 days previously.
Argentina tests performed total 192430ppm (19%) at 780ppm/day.
36% of tests are positive - currently 57%.
Vaccinations at 190100ppm (19.0%) with 2.6% vaccinated.

Mexico detections at 18295ppm (1.8%)
Detection rate is 20ppm/day and leveling below 30ppm/day.
Fatalities are 1692ppm at 1.9ppm/day.
FR is 9.3% from a 18186ppm detection recorded 7 days previously.
Mexico tests performed total 48300ppm (4.8%), at 90ppm/day.
38% of tests are positive - currently 22%.
Vaccinations at 154700ppm (15.5%) with 6.8% vaccinated.

South Africa detections at 26815ppm (2.7%)
Detection rate is 26ppm/day and possibly leveling below 30ppm/day.
Fatalities are 921ppm at 0.7ppm/day.
FR is 3.5% from a 26661ppm detection recorded 7 days previously.
SA tests performed total 180680ppm (18.1%) at 410ppm/day.
14.8% of tests are positive - currently 6.3%.
Vaccinations at 6200ppm (~0.6%) with ~0.6% vaccinated.

Czech detections at 153247ppm (15.3%)
Detection rate is 168ppm/day and falling.
Fatalities are 2757ppm at 4.1ppm/day.
FR is 1.8% from a 152279ppm detection recorded 7 days previously.
Czech tests are unreported (~65%), at 15490ppm/day.
No test positivity rate is possible - currently 1.1%.
Vaccinations at 327700ppm (32.8%) with 9.8% vaccinated.

India detections at 15574ppm (1.6%)
Detection rate is 282ppm/day and rising to levels not seen previously.
Fatalities at 170ppm at 2.7ppm/day.
FR is 1.2% from a 13888ppm detection recorded 7 days previously.
Indian tests performed total 212540ppm (21%) at 1280ppm/day.
7.3% of tests are positive - currently 22.0%.
Vaccinations at 117800ppm (11.8%) with 2.3% vaccinated.

Isreal detections at 96912ppm (9.7%)
Detection rate is 7ppm/day and leveling below 10ppm/day
Fatalities at 736ppm at 0.2ppm/day.
FR is 0.8% from a 96872ppm detection recorded 7 days previously.
Israeli tests performed total 1878240ppm (188%) at 3600ppm/day.
5.2% of tests are positive - currently 0.2%
Vaccinations at 1211800ppm (121%) with 58.6% vaccinated.

>
> Chile participated in Phase 3 trials for AstraZeneca,
> Johnson & Johnson, Sinovac and CanSino. Chile has contracts
> with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
> Sinovac is their regular supplier of seasonal flu vaccine.
> Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
> temperatures. About 60% of Chile's contracted 80 million doses
> are from Sinovac.
>
> Chile maintains a Public Health service database that includes
> regular vaccination scheduling. Using these resources alone
> allowed vaccination rates as high as 1 million doses per week
> to be delivered as early as mid-February. Approval of vaccine
> use was based on published Phase 1 and Phase 2 reporting.
>
> multiply ppm by population (in millions) for real numbers.
> China - 1397 million
> Iceland - 0.36 million
> US - 330 million
> Canada - 37 million
> Italy - 60 million
> Sweden - 10 million
> UK - 66 million
> Brazil - 210 million
> Peru - 32 million
> Chile - 19 million
> Argentina - 45 million
> Mexico - 127 million
> South Africa - 58 million
> Czech Republic - 10.7 million
> Israel - 10 million
> India - 1391 million

RL

> Per capita comparisons are interesting, as they represent
> efforts, within political boundaries, equally.
> Data is easily obtained by visiting the data explorer page
> at Our World in Data:

> http://tiny.cc/ul41tz

>
> A 100ppm daily detection rate would, in one year, result in
> an approximately 4% penetration within the population.
>
> Testing of blood donor samples in Quebec suggests that covid-19
> antibodies are present in the local population at 3x positive
> virus detection test rate.
>
> Median age in Germany and Italy is 45-46yrs.
> Median age in Canada, UK and Sweden is 40-41yrs.
> Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively.
> Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
> Median age in Israel is 30.4yrs.
> Median age in Peru and Mexico is 27.5yrs.
> Median age in India is 26.8yrs.
> Median age in South Africa is 25yrs.
>
>
> Comparison charts, as of Apr 30 are available:
> http://ve3ute.ca/query/210430_cases_ppm_major.jpg
> http://ve3ute.ca/query/210430_cases_ppm_report_group.jpg
> http://ve3ute.ca/query/210430_deaths_daily_ppm_report_group.jpg
> http://ve3ute.ca/query/210430_deaths_ppm_report_group.jpg
> http://ve3ute.ca/query/210430_vaccinations_report_group.jpg
> http://ve3ute.ca/query/210430_vaccinations_major.jpg
>
>
>
> Flu Season? Fatality comparison in the U.S.A.
> http://ve3ute.ca/query/flu_season_020.jpg
> Updated Apr30
>

> Israel, with >120% of vaccine doses applied to vaccinate 58% of
> the population, reports a daily virus detection rate below 15ppm
> and a 0.2ppm/day fatality rate. These figures have not altered
> significantly in the last 30 days - indicating the end of
> Pfizer's vaccination trial.

> The US, UK and Chile have all issued >70% of vaccine doses, with
> vaccination rates of 29%, 21% and 34% respectively. Detection
> rates have stabilized in all three nations, but at levels that
> do not correlate to one another.

As of May10:
US detections are at 98814ppm.(9.9%)
Detection rate is 123ppm/day and falling.
Fatalities are 1758ppm at 2.0ppm/day
FR is 1.8% from a 98103ppm detection recorded 7 days previously.
US tests total 1274650ppm (127%) at 2660ppm/day
7.8% of tests are positive - currently 4.6%.
Vaccinations at 776660ppm (77.7%) with 34.2% vaccinated.

Canada detections at 34275ppm (3.4%) ~ 174 days behind the US.
Detection rate at 200ppm/day and possibly leveling at ~210ppm/day.
Fatalities are 651ppm at 1.2ppm/day.
FR is 2.0% from a 33167ppm detection recorded 7 days previously.
Canada tests total 854910ppm (85%) at 3560ppm/day
4.0% of tests are positive - currently at 5.6%.
Vaccinations at 421700ppm (42.2%) with 3.3% vaccinated.

Italian detections at 67997ppm. (6.8%)
Detection rate is 157ppm/day and falling.
Fatalities are 2032ppm at 3.9ppm/day.
FR is 3.0% from a 66996ppm detection recorded 7 days previously.
Italian tests total 995740ppm (100%) - at 4640ppm/day.
6.8% of tests are positive - currently 3.4%.
Vaccinations at 397800ppm (37.5%) with 12.2% vaccinated.

Sweden detections at 102599ppm. (10.3%)
Detection rate is 484ppm/day and falling.
Fatalities are 1403ppm at 1.8ppm/day.
FR is 1.4% from a 96978ppm detection recorded 7 days previously.
Sweden tests performed are unreported at ~4640ppm/day
No test positivity rate is possible - currently 10.4%
Vaccinations at 364300ppm (36.4%) with 8.2% vaccinated.

UK detections at 65650ppm. (6.6%)
Detection rate is 31ppm/day and leveling below 40ppm/day.
Fatalities are 1883ppm at 0.1ppm/day.
FR is 2.9% from a 65376ppm detection recorded 7 days previously.
UK tests total 2332780ppm (233%) at 14410ppm/day.
2.8% of tests are positive - currently 0.2%.
Vaccinations at 781300ppm (78.1%) with 26.0% vaccinated

Brazil detections at 71438ppm. (7.1%)
Detection rate is 289ppm/day and rising.
Fatalities are 1987ppm at 9.9ppm/day.
FR is 2.8% from a 69531ppm detection recorded 7 days previously.
Brazil tests performed are unreported.
No test positivity rate is possible.
Vaccinations at 220500ppm (22.1%) with 7.1% vaccinated.

Peru detections at 56117ppm (5.6%)
Detection rate is 170ppm/day and falling.
Fatalities are 1944ppm at 8.6ppm/day.
FR is 3.5% from a 55020ppm detection recorded 7 days previously.
Peru tests performed are unreported.
No test positivity rate is possible.
Vaccinations at 58800ppm (5.9%) with 2.0% vaccinated

Chile detections at 65237ppm (6.5%)
Detection rate is 273ppm/day and falling.
Fatalities are 1424ppm at 4.9ppm/day.
FR is 2.3% from a 61716ppm detection recorded 14 days previously.
Chile tests performed 699230ppm (70%) - at 2890ppm/day.
9.3% of tests are positive - currently 9.4%.
Vaccinations at 800200ppm (80.0%) with 36.6% vaccinated.

Argentina detections at 69647ppm (7.0%)
Detection rate is 450ppm/day and possibly leveling below 460ppm/day.
Fatalities are 1490ppm at 9.7ppm/day.
FR is 2.2% from a 66847ppm detection recorded 7 days previously.
Argentina tests performed total 194990ppm (19%) at 720ppm/day.
36% of tests are positive - currently 63%.
Vaccinations at 201000ppm (20.1%) with 3.1% vaccinated.

Mexico detections at 18349ppm (1.8%)
Detection rate is 19ppm/day and leveling below 30ppm/day.
Fatalities are 1698ppm at 2.0ppm/day.
FR is 9.3% from a 18226ppm detection recorded 7 days previously.
Mexico tests performed total 48700ppm (4.9%), at 80ppm/day.
38% of tests are positive - currently 24%.
Vaccinations at 164600ppm (16.5%) with 7.3% vaccinated.

South Africa detections at 26920ppm (2.7%)
Detection rate is 30ppm/day and possibly leveling below 30ppm/day.
Fatalities are 923ppm at 0.8ppm/day.
FR is 3.5% from a 26724ppm detection recorded 7 days previously.
SA tests performed total 182200ppm (18.2%) at 430ppm/day.
14.8% of tests are positive - currently 7.0%.
Vaccinations at 6400ppm (0.6%) with 0.6% vaccinated.

Czech detections at 153615ppm (15.3%)
Detection rate is 146ppm/day and falling.
Fatalities are 2770ppm at 4.3ppm/day.
FR is 1.8% from a 152640ppm detection recorded 7 days previously.
Czech tests are unreported (~65%), at 15800ppm/day.
No test positivity rate is possible - currently 0.9%.
Vaccinations at 341200ppm (34.1%) with 9.9% vaccinated.

India detections at 16422ppm (1.6%)
Detection rate is 283ppm/day and rising to levels not seen previously.
Fatalities at 178ppm at 2.8ppm/day.
FR is 1.2% from a 14698ppm detection recorded 7 days previously.
Indian tests performed total 216380ppm (22%) at 1260ppm/day.
7.6% of tests are positive - currently 14.1%.
Vaccinations at 122000ppm (12.2%) with 2.5% vaccinated.

Isreal detections at 96920ppm (9.7%)
Detection rate is 6ppm/day and leveling below 10ppm/day
Fatalities at 737ppm at 0.2ppm/day.
FR is 0.8% from a 96888ppm detection recorded 7 days previously.
Israeli tests performed total 1886140ppm (189%) at 3700ppm/day.
5.1% of tests are positive - currently 0.2%
Vaccinations at 1213200ppm (121%) with 58.7% vaccinated.

>
> Chile participated in Phase 3 trials for AstraZeneca,
> Johnson & Johnson, Sinovac and CanSino. Chile has contracts
> with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
> Sinovac is their regular supplier of seasonal flu vaccine.
> Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
> temperatures. About 60% of Chile's contracted 80 million doses
> are from Sinovac.
>
> Chile maintains a Public Health service database that includes
> regular vaccination scheduling. Using these resources alone
> allowed vaccination rates as high as 1 million doses per week
> to be delivered as early as mid-February. Approval of vaccine
> use was based on published Phase 1 and Phase 2 reporting.
>
> multiply ppm by population (in millions) for real numbers.
> China - 1397 million
> Iceland - 0.36 million
> US - 330 million
> Canada - 37 million
> Italy - 60 million
> Sweden - 10 million
> UK - 66 million
> Brazil - 210 million
> Peru - 32 million
> Chile - 19 million
> Argentina - 45 million
> Mexico - 127 million
> South Africa - 58 million
> Czech Republic - 10.7 million
> Israel - 10 million
> India - 1391 million

RL

> Per capita comparisons are interesting, as they represent
> efforts, within political boundaries, equally.
> Data is easily obtained by visiting the data explorer page
> at Our World in Data:

> http://tiny.cc/ul41tz

>
> A 100ppm daily detection rate would, in one year, result in
> an approximately 4% penetration within the population.
>
> Testing of blood donor samples in Quebec suggests that covid-19
> antibodies are present in the local population at 3x positive
> virus detection test rate.
>
> Median age in Germany and Italy is 45-46yrs.
> Median age in Canada, UK and Sweden is 40-41yrs.
> Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively.
> Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
> Median age in Israel is 30.4yrs.
> Median age in Peru and Mexico is 27.5yrs.
> Median age in India is 26.8yrs.
> Median age in South Africa is 25yrs.
>
>
> Comparison charts, as of Apr 30 are available:
> http://ve3ute.ca/query/210430_cases_ppm_major.jpg
> http://ve3ute.ca/query/210430_cases_ppm_report_group.jpg
> http://ve3ute.ca/query/210430_deaths_daily_ppm_report_group.jpg
> http://ve3ute.ca/query/210430_deaths_ppm_report_group.jpg
> http://ve3ute.ca/query/210430_vaccinations_report_group.jpg
> http://ve3ute.ca/query/210430_vaccinations_major.jpg
>
>
>
> Flu Season? Fatality comparison in the U.S.A.
> http://ve3ute.ca/query/flu_season_020.jpg
> Updated Apr30
>

> Israel, with >120% of vaccine doses applied to vaccinate 58% of
> the population, reports a daily virus detection rate below 15ppm
> and a 0.2ppm/day fatality rate. These figures have not altered
> significantly in the last 30 days - indicating the end of
> Pfizer's vaccination trial.

The US, UK and Chile have all issued >80% of vaccine doses, with
vaccination rates of 35%, 27% and 38% respectively. Detection
rates have stabilized in all three nations, but at levels that
do not correlate to one another.

As of May13:
US detections are at 99138ppm.(9.9%)
Detection rate is 111ppm/day and falling.
Fatalities are 1763ppm at 1.9ppm/day
FR is 1.8% from a 98504ppm detection recorded 7 days previously.
US tests total 1288630ppm (129%) at 2610ppm/day
7.7% of tests are positive - currently 4.3%.
Vaccinations at 791400ppm (79.1%) with 35.2% vaccinated.

Canada detections at 34826ppm (3.5%) ~ 177 days behind the US.
Detection rate at 182ppm/day and falling.
Fatalities are 656ppm at 1.2ppm/day.
FR is 2.0% from a 33965ppm detection recorded 7 days previously.
Canada tests total 867640ppm (87%) at 3210ppm/day
4.0% of tests are positive - currently at 5.7%.
Vaccinations at 447900ppm (44.8%) with 3.5% vaccinated.

Italian detections at 68325ppm. (6.8%)
Detection rate is 143ppm/day and falling.
Fatalities are 2043ppm at 3.6ppm/day.
FR is 3.0% from a 67517ppm detection recorded 7 days previously.
Italian tests total 1012660ppm (101%) - at 4700ppm/day.
6.7% of tests are positive - currently 3.0%.
Vaccinations at 420200ppm (42.0%) with 13.1% vaccinated.

Sweden detections at 102194ppm. (10.2%)
Detection rate is 457ppm/day and falling.
Fatalities are 1413ppm at 1.6ppm/day.
FR is 1.4% from a 99227ppm detection recorded 7 days previously.
Sweden tests performed are unreported at ~4890ppm/day
No test positivity rate is possible - currently 9.3%
Vaccinations at 391900ppm (39.2%) with 8.9% vaccinated.

UK detections at 65665ppm. (6.6%)
Detection rate is 34ppm/day and leveling below 40ppm/day.
Fatalities are 1884ppm at 0.2ppm/day.
FR is 2.9% from a 65376ppm detection recorded 7 days previously.
UK tests total 2389690ppm (239%) at 15460ppm/day.
2.7% of tests are positive - currently 0.2%.
Vaccinations at 797800ppm (79.8%) with 27.2% vaccinated

Brazil detections at 72259ppm. (7.2%)
Detection rate is 288ppm/day and possibly leveling below 300ppm/day.
Fatalities are 2014ppm at 9.2ppm/day.
FR is 2.9% from a 70585ppm detection recorded 7 days previously.
Brazil tests performed are unreported.
No test positivity rate is possible.
Vaccinations at 231400ppm (23.1%) with 7.5% vaccinated.

Peru detections at 56583ppm (5.7%)
Detection rate is 203ppm/day and possibly leveling below 210ppm/day.
Fatalities are 1968ppm at 9.6ppm/day.
FR is 3.6% from a 55334ppm detection recorded 7 days previously.
Peru tests performed are unreported.
No test positivity rate is possible.
Vaccinations at 66700ppm (6.7%) with 2.2% vaccinated

Chile detections at 65936ppm (6.6%)
Detection rate is 280ppm/day and falling.
Fatalities are 1432ppm at 4.9ppm/day.
FR is 2.3% from a 62682ppm detection recorded 14 days previously.
Chile tests performed 712670ppm (71%) - at 2840ppm/day.
9.3% of tests are positive - currently 9.9%.
Vaccinations at 840300ppm (84.0%) with 38.2% vaccinated.

Argentina detections at 71148ppm (7.1%)
Detection rate is 455ppm/day and possibly leveling below 460ppm/day.
Fatalities are 1522ppm at 9.3ppm/day.
FR is 2.2% from a 68493ppm detection recorded 7 days previously.
Argentina tests performed total 198050ppm (20%) at 710ppm/day.
36% of tests are positive - currently 64%.
Vaccinations at 207600ppm (20.8%) with 3.4% vaccinated.

Mexico detections at 18393ppm (1.8%)
Detection rate is 17ppm/day and leveling below 30ppm/day.
Fatalities are 1702ppm at 1.8ppm/day.
FR is 9.3% from a 18295ppm detection recorded 7 days previously.
Mexico tests performed total 49070ppm (4.9%), at 80ppm/day.
38% of tests are positive - currently 21%.
Vaccinations at 165200ppm (16.5%) with 7.4% vaccinated.

South Africa detections at 27012ppm (2.7%)
Detection rate is 33ppm/day and possibly leveling around 30ppm/day.
Fatalities are 927ppm at 1.0ppm/day.
FR is 3.5% from a 26815ppm detection recorded 7 days previously.
SA tests performed total 183890ppm (18.4%) at 460ppm/day.
14.8% of tests are positive - currently 7.2%.
Vaccinations at 7300ppm (0.7%) with 0.7% vaccinated.

Czech detections at 153952ppm (15.4%)
Detection rate is 126ppm/day and falling.
Fatalities are 2782ppm at 4.1ppm/day.
FR is 1.8% from a 153247ppm detection recorded 7 days previously.
Czech tests are unreported, at 16370ppm/day.
No test positivity rate is possible - currently 0.8%.
Vaccinations at 364300ppm (36.4%) with 10.1% vaccinated.

India detections at 17177ppm (1.7%)
Detection rate is 272ppm/day and falling.
Fatalities at 187ppm at 2.9ppm/day.
FR is 1.2% from a 15574ppm detection recorded 7 days previously.
Indian tests performed total 221450ppm (22%) at 1270ppm/day.
7.7% of tests are positive - currently 21.4%.
Vaccinations at 127600ppm (12.8%) with 2.8% vaccinated.

Isreal detections at 96936ppm (9.7%)
Detection rate is 4ppm/day and leveling below 10ppm/day
Fatalities at 737ppm at 0.2ppm/day.
FR is 0.8% from a 96912ppm detection recorded 7 days previously.
Israeli tests performed total 1899230ppm (190%) at 3710ppm/day.
5.1% of tests are positive - currently 0.1%
Vaccinations at 1215400ppm (122%) with 58.8% vaccinated.

>
> Chile participated in Phase 3 trials for AstraZeneca,
> Johnson & Johnson, Sinovac and CanSino. Chile has contracts
> with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
> Sinovac is their regular supplier of seasonal flu vaccine.
> Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
> temperatures. About 60% of Chile's contracted 80 million doses
> are from Sinovac.
>
> Chile maintains a Public Health service database that includes
> regular vaccination scheduling. Using these resources alone
> allowed vaccination rates as high as 1 million doses per week
> to be delivered as early as mid-February. Approval of vaccine
> use was based on published Phase 1 and Phase 2 reporting.
>
> multiply ppm by population (in millions) for real numbers.
> China - 1397 million
> Iceland - 0.36 million
> US - 330 million
> Canada - 37 million
> Italy - 60 million
> Sweden - 10 million
> UK - 66 million
> Brazil - 210 million
> Peru - 32 million
> Chile - 19 million
> Argentina - 45 million
> Mexico - 127 million
> South Africa - 58 million
> Czech Republic - 10.7 million
> Israel - 10 million
> India - 1391 million

RL

Rob, is anyone tracking infection (hospitalization, death, etc.) rates as
differentiated by vaccination status (and, ideally, vaccine used)?

In article <hcsj9glct7i2v4ul5p70h9v004rd9mhk6g@4ax.com>,
legg <legg@nospam.magma.ca> wrote:
<SNIP>
>Isreal detections at 96920ppm (9.7%)
>Detection rate is 6ppm/day and leveling below 10ppm/day
>Fatalities at 737ppm at 0.2ppm/day.
>FR is 0.8% from a 96888ppm detection recorded 7 days previously.
>Israeli tests performed total 1886140ppm (189%) at 3700ppm/day.
>5.1% of tests are positive - currently 0.2%
>Vaccinations at 1213200ppm (121%) with 58.7% vaccinated.

Does that include the 5 million people living in the "thuislanden"
or is it <"slegs vir blankes" >?

<SNIP>
>RL

Groetjes Albert
--
"in our communism country Viet Nam, people are forced to be
alive and in the western country like US, people are free to
die from Covid 19 lol" duc ha
albert@spe&ar&c.xs4all.nl &=n http://home.hccnet.nl/a.w.m.van.der.horst

On Thu, 13 May 2021 12:20:53 -0700, Don Y
<blockedofcourse@foo.invalid> wrote:

>Rob, is anyone tracking infection (hospitalization, death, etc.) rates as
>differentiated by vaccination status (and, ideally, vaccine used)?

The only vaccine-type-related statistic that I see regularly reported
is VITT occurence rates for the AZ and J&J types..

The UK has collected info on post-vaccine-related results, sufficient
to convince most authorities that a single dose of any will reduce
Intensive Care Unit bed occupancy and fatality rates.

I believe that in the UK, vaccines are used 'as directed', with no
fuzzy definitions about second dose intervals, so this information
is drawn from ~30 day period dosing. Regions where this is assumed
to cover longer intervals between doses have yet to report useful
statistics - it would take more than 3x longer to do so.

RL

On 5/14/2021 8:25 AM, legg wrote:
> On Thu, 13 May 2021 12:20:53 -0700, Don Y
> <blockedofcourse@foo.invalid> wrote:
>
>> Rob, is anyone tracking infection (hospitalization, death, etc.) rates as
>> differentiated by vaccination status (and, ideally, vaccine used)?
>
> The only vaccine-type-related statistic that I see regularly reported
> is VITT occurence rates for the AZ and J&J types..

So, they're only "worried" about "adverse effects".

You'd think htey would also try to harvest efficacy data -- have PCPs report
covid-like illness and whether or not the pt was vaccinated; ditto for
hospitals. In addition to fleshing out the *actual* (?) efficacy, it
would also provide an *insight* into how long immunity lasts.

> The UK has collected info on post-vaccine-related results, sufficient
> to convince most authorities that a single dose of any will reduce
> Intensive Care Unit bed occupancy and fatality rates.

Yet another "cost avoidance" issue. But, still doesn't attest to how
effective the vaccine(s) are, in practice.

> I believe that in the UK, vaccines are used 'as directed', with no
> fuzzy definitions about second dose intervals, so this information
> is drawn from ~30 day period dosing. Regions where this is assumed
> to cover longer intervals between doses have yet to report useful
> statistics - it would take more than 3x longer to do so.

Here (US) we should start to see data on the long-term effects
as we're already 3 months out for some pts. Waiting until ~9 months
to start noticing patterns seems a bit late...

On Thu, 13 May 2021 12:20:53 -0700, Don Y
<blockedofcourse@foo.invalid> wrote:

>Rob, is anyone tracking infection (hospitalization, death, etc.) rates as
>differentiated by vaccination status (and, ideally, vaccine used)?

The University of Birmingham released a study a week ago that looked
at 30day to 12 week immunity response of the Pfizer vaccine.

https://www.birmingham.ac.uk/news/latest/2021/05/covid-pfizer-vaccination-interval-antibody-response.aspx

So there is obviously some capacity to compare the effects of
different vaccines, where funding permits.

Admittedly, 'antibody response' is not likely to be one of the
typical features of a case study parameter; vaccination dates
hospitalization and fatality, however, couldn't fail to be
included in the UK's National Health records for the NIHR.

RL

On 5/14/2021 9:01 PM, legg wrote:
> On Thu, 13 May 2021 12:20:53 -0700, Don Y
> <blockedofcourse@foo.invalid> wrote:
>
>> Rob, is anyone tracking infection (hospitalization, death, etc.) rates as
>> differentiated by vaccination status (and, ideally, vaccine used)?
>
> The University of Birmingham released a study a week ago that looked
> at 30day to 12 week immunity response of the Pfizer vaccine.
>
> https://www.birmingham.ac.uk/news/latest/2021/05/covid-pfizer-vaccination-interval-antibody-response.aspx
>
> So there is obviously some capacity to compare the effects of
> different vaccines, where funding permits.

What I'm talking about is the relative ease of *collecting* the
data -- *if* someone mandates it. The analysis "funding"
is a separate issue.

Here (US), we have "reportable diseases" -- Dxs that require the
physician to "report" the Dx to the "local authorities". It is
typically used to track highly contagious diseases (i.e., you
want a "heads up" if you start to see a measles outbreak; you
don't want to rely on an individual doctor to know what may be
happening in other offices/clinics around town!). Or, diseases
that have other potential "public health" importance.

E.g., a case of Hanta Virus likely wants to be investigated
as soon as it is "reported" as the consequences of it getting out
of control are serious.

Reportable diseases have different reporting requirements
as befitting the risk posed by the disease incident.

In some cases, you (the medical practitioner, NOT the pt) are
just interested in a count. In other cases, you might have
to prepare a written accounting of the individual case.

I *think* most folks would have no problem considering covid to be
of significant "public health" importance! :>

So, it seems logical that making it reportable and requiring
"vaccination status" to be a part of that report to be a
simple way of *collecting* the data. Going *back*, in time,
to try to reconstruct the data would be an exercise in futility.
And, a significant burden on providers (if the pt presented at
an ER, would the ER have to track the pt down, later, to inquire
as to his immunization status AT THE TIME HE PRESENTED?)

> Admittedly, 'antibody response' is not likely to be one of the
> typical features of a case study parameter; vaccination dates
> hospitalization and fatality, however, couldn't fail to be
> included in the UK's National Health records for the NIHR.

If (as seems likely) covid becomes endemic, then any
data gathering opportunities that are overlooked seems
a foolish waste.

On Sat, 15 May 2021 13:25:02 -0700, Don Y
<blockedofcourse@foo.invalid> wrote:

>On 5/14/2021 9:01 PM, legg wrote:
>> On Thu, 13 May 2021 12:20:53 -0700, Don Y
>> <blockedofcourse@foo.invalid> wrote:
>>
>>> Rob, is anyone tracking infection (hospitalization, death, etc.) rates as
>>> differentiated by vaccination status (and, ideally, vaccine used)?
>>
>> The University of Birmingham released a study a week ago that looked
>> at 30day to 12 week immunity response of the Pfizer vaccine.
>>
>> https://www.birmingham.ac.uk/news/latest/2021/05/covid-pfizer-vaccination-interval-antibody-response.aspx
>>
>> So there is obviously some capacity to compare the effects of
>> different vaccines, where funding permits.
>
>What I'm talking about is the relative ease of *collecting* the
>data -- *if* someone mandates it. The analysis "funding"
>is a separate issue.
>
>Here (US), we have "reportable diseases" -- Dxs that require the
>physician to "report" the Dx to the "local authorities". It is
>typically used to track highly contagious diseases (i.e., you
>want a "heads up" if you start to see a measles outbreak; you
>don't want to rely on an individual doctor to know what may be
>happening in other offices/clinics around town!). Or, diseases
>that have other potential "public health" importance.
>
>E.g., a case of Hanta Virus likely wants to be investigated
>as soon as it is "reported" as the consequences of it getting out
>of control are serious.
>
>Reportable diseases have different reporting requirements
>as befitting the risk posed by the disease incident.
>
>In some cases, you (the medical practitioner, NOT the pt) are
>just interested in a count. In other cases, you might have
>to prepare a written accounting of the individual case.
>
>I *think* most folks would have no problem considering covid to be
>of significant "public health" importance! :>
>
>So, it seems logical that making it reportable and requiring
>"vaccination status" to be a part of that report to be a
>simple way of *collecting* the data. Going *back*, in time,
>to try to reconstruct the data would be an exercise in futility.
>And, a significant burden on providers (if the pt presented at
>an ER, would the ER have to track the pt down, later, to inquire
>as to his immunization status AT THE TIME HE PRESENTED?)
>
>> Admittedly, 'antibody response' is not likely to be one of the
>> typical features of a case study parameter; vaccination dates
>> hospitalization and fatality, however, couldn't fail to be
>> included in the UK's National Health records for the NIHR.
>
>If (as seems likely) covid becomes endemic, then any
>data gathering opportunities that are overlooked seems
>a foolish waste.

I don't know how it works in the UK under NHS, but
in Canada your contact with medical professionals or a
health care provider is documented in a patient-specific
record associated with a registration number - if the
Doctor, health care provider or pharmacist expects to
be reimbursed under the health care program for the
service(s) being provided.

Reportable illnesses require added paperwork. I'm not
sure who ends up paying for that administration time,
or who is looking at the results on any particular
schedule. Supposedly some (ie infectious diseases) are
considered more time-sensitive than others.

RL

On 5/15/2021 2:32 PM, legg wrote:
> On Sat, 15 May 2021 13:25:02 -0700, Don Y
> <blockedofcourse@foo.invalid> wrote:
>
>> On 5/14/2021 9:01 PM, legg wrote:
>>> On Thu, 13 May 2021 12:20:53 -0700, Don Y
>>> <blockedofcourse@foo.invalid> wrote:
>>>
>>>> Rob, is anyone tracking infection (hospitalization, death, etc.) rates as
>>>> differentiated by vaccination status (and, ideally, vaccine used)?
>>>
>>> The University of Birmingham released a study a week ago that looked
>>> at 30day to 12 week immunity response of the Pfizer vaccine.
>>>
>>> https://www.birmingham.ac.uk/news/latest/2021/05/covid-pfizer-vaccination-interval-antibody-response.aspx
>>>
>>> So there is obviously some capacity to compare the effects of
>>> different vaccines, where funding permits.
>>
>> What I'm talking about is the relative ease of *collecting* the
>> data -- *if* someone mandates it. The analysis "funding"
>> is a separate issue.
>>
>> Here (US), we have "reportable diseases" -- Dxs that require the
>> physician to "report" the Dx to the "local authorities". It is
>> typically used to track highly contagious diseases (i.e., you
>> want a "heads up" if you start to see a measles outbreak; you
>> don't want to rely on an individual doctor to know what may be
>> happening in other offices/clinics around town!). Or, diseases
>> that have other potential "public health" importance.
>>
>> E.g., a case of Hanta Virus likely wants to be investigated
>> as soon as it is "reported" as the consequences of it getting out
>> of control are serious.
>>
>> Reportable diseases have different reporting requirements
>> as befitting the risk posed by the disease incident.
>>
>> In some cases, you (the medical practitioner, NOT the pt) are
>> just interested in a count. In other cases, you might have
>> to prepare a written accounting of the individual case.
>>
>> I *think* most folks would have no problem considering covid to be
>> of significant "public health" importance! :>
>>
>> So, it seems logical that making it reportable and requiring
>> "vaccination status" to be a part of that report to be a
>> simple way of *collecting* the data. Going *back*, in time,
>> to try to reconstruct the data would be an exercise in futility.
>> And, a significant burden on providers (if the pt presented at
>> an ER, would the ER have to track the pt down, later, to inquire
>> as to his immunization status AT THE TIME HE PRESENTED?)
>>
>>> Admittedly, 'antibody response' is not likely to be one of the
>>> typical features of a case study parameter; vaccination dates
>>> hospitalization and fatality, however, couldn't fail to be
>>> included in the UK's National Health records for the NIHR.
>>
>> If (as seems likely) covid becomes endemic, then any
>> data gathering opportunities that are overlooked seems
>> a foolish waste.
>
> I don't know how it works in the UK under NHS, but
> in Canada your contact with medical professionals or a
> health care provider is documented in a patient-specific
> record associated with a registration number - if the

Here, I believe your "MRN" is only tied to your PCP.
I.e., if I go to a hospital in another town, they
just know me by my name; my "records" are likely not
accessible to that provider. (we have "islands" of
data, not a continuum)

> Doctor, health care provider or pharmacist expects to
> be reimbursed under the health care program for the
> service(s) being provided.

The pt is ultimately responsible. So, the provider wants
a way of getting back to *you* (e.g., if your insurance
denies the claim, the provider isn't going to just eat it)

> Reportable illnesses require added paperwork. I'm not
> sure who ends up paying for that administration time,
> or who is looking at the results on any particular
> schedule. Supposedly some (ie infectious diseases) are
> considered more time-sensitive than others.

As everything in the US is "fee for service", I'm sure there
is a code for "report illness to local health agencies"
that the provider "checks".

Note that reporting may be as simple as placing a phone
call or as involved as documenting the individual case.

Regardless, when the gummit is absorbing all of these
other costs associated with covid, you'd think tacking on
that additional requirement (and fee) would be a no-brainer.

On Sat, 15 May 2021 15:39:09 -0700, Don Y
<blockedofcourse@foo.invalid> wrote:

>On 5/15/2021 2:32 PM, legg wrote:
>> On Sat, 15 May 2021 13:25:02 -0700, Don Y
>> <blockedofcourse@foo.invalid> wrote:
>>
>>> On 5/14/2021 9:01 PM, legg wrote:
>>>> On Thu, 13 May 2021 12:20:53 -0700, Don Y
>>>> <blockedofcourse@foo.invalid> wrote:
>>>>
>>>>> Rob, is anyone tracking infection (hospitalization, death, etc.) rates as
>>>>> differentiated by vaccination status (and, ideally, vaccine used)?
>>>>
>>>> The University of Birmingham released a study a week ago that looked
>>>> at 30day to 12 week immunity response of the Pfizer vaccine.
>>>>
>>>> https://www.birmingham.ac.uk/news/latest/2021/05/covid-pfizer-vaccination-interval-antibody-response.aspx
>>>>
>>>> So there is obviously some capacity to compare the effects of
>>>> different vaccines, where funding permits.
>>>
>>> What I'm talking about is the relative ease of *collecting* the
>>> data -- *if* someone mandates it. The analysis "funding"
>>> is a separate issue.
>>>
>>> Here (US), we have "reportable diseases" -- Dxs that require the
>>> physician to "report" the Dx to the "local authorities". It is
>>> typically used to track highly contagious diseases (i.e., you
>>> want a "heads up" if you start to see a measles outbreak; you
>>> don't want to rely on an individual doctor to know what may be
>>> happening in other offices/clinics around town!). Or, diseases
>>> that have other potential "public health" importance.
>>>
>>> E.g., a case of Hanta Virus likely wants to be investigated
>>> as soon as it is "reported" as the consequences of it getting out
>>> of control are serious.
>>>
>>> Reportable diseases have different reporting requirements
>>> as befitting the risk posed by the disease incident.
>>>
>>> In some cases, you (the medical practitioner, NOT the pt) are
>>> just interested in a count. In other cases, you might have
>>> to prepare a written accounting of the individual case.
>>>
>>> I *think* most folks would have no problem considering covid to be
>>> of significant "public health" importance! :>
>>>
>>> So, it seems logical that making it reportable and requiring
>>> "vaccination status" to be a part of that report to be a
>>> simple way of *collecting* the data. Going *back*, in time,
>>> to try to reconstruct the data would be an exercise in futility.
>>> And, a significant burden on providers (if the pt presented at
>>> an ER, would the ER have to track the pt down, later, to inquire
>>> as to his immunization status AT THE TIME HE PRESENTED?)
>>>
>>>> Admittedly, 'antibody response' is not likely to be one of the
>>>> typical features of a case study parameter; vaccination dates
>>>> hospitalization and fatality, however, couldn't fail to be
>>>> included in the UK's National Health records for the NIHR.
>>>
>>> If (as seems likely) covid becomes endemic, then any
>>> data gathering opportunities that are overlooked seems
>>> a foolish waste.
>>
>> I don't know how it works in the UK under NHS, but
>> in Canada your contact with medical professionals or a
>> health care provider is documented in a patient-specific
>> record associated with a registration number - if the
>
>Here, I believe your "MRN" is only tied to your PCP.
>I.e., if I go to a hospital in another town, they
>just know me by my name; my "records" are likely not
>accessible to that provider. (we have "islands" of
>data, not a continuum)
>
>> Doctor, health care provider or pharmacist expects to
>> be reimbursed under the health care program for the
>> service(s) being provided.
>
>The pt is ultimately responsible. So, the provider wants
>a way of getting back to *you* (e.g., if your insurance
>denies the claim, the provider isn't going to just eat it)
>
>> Reportable illnesses require added paperwork. I'm not
>> sure who ends up paying for that administration time,
>> or who is looking at the results on any particular
>> schedule. Supposedly some (ie infectious diseases) are
>> considered more time-sensitive than others.
>
>As everything in the US is "fee for service", I'm sure there
>is a code for "report illness to local health agencies"
>that the provider "checks".
>
>Note that reporting may be as simple as placing a phone
>call or as involved as documenting the individual case.
>
>Regardless, when the gummit is absorbing all of these
>other costs associated with covid, you'd think tacking on
>that additional requirement (and fee) would be a no-brainer.

I can see it now - surrender privacy to get a shot - howls
from everywhere, in the States.

RL

On 5/16/2021 7:25 AM, legg wrote:

>> Regardless, when the gummit is absorbing all of these
>> other costs associated with covid, you'd think tacking on
>> that additional requirement (and fee) would be a no-brainer.
>
> I can see it now - surrender privacy to get a shot - howls
> from everywhere, in the States.

Note that I was discussing getting *treated* (Dx-ed) for
covid, not *vaccinated*. Though I believe the gummit
is (was?) underwriting much of the cost of *care*
during the pandemic (were providers required to report
pt identities?)

You already *do* "surrender privacy" to get vaccinated
(if you consider the fact that you have to provide
an ID -- the information on which is transcribed into
an "official record" -- to get the shot)

And, of course, the microchip that is contained in the
injected serum (to track your location, 24/7/365!)

<rolls eyes>

> Per capita comparisons are interesting, as they represent
> efforts, within political boundaries, equally.
> Data is easily obtained by visiting the data explorer page
> at Our World in Data:

> http://tiny.cc/ul41tz

>
> A 100ppm daily detection rate would, in one year, result in
> an approximately 4% penetration within the population.
>
> Testing of blood donor samples in Quebec suggests that covid-19
> antibodies are present in the local population at 3x positive
> virus detection test rate.
>
> Median age in Germany and Italy is 45-46yrs.
> Median age in Canada, UK and Sweden is 40-41yrs.
> Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively.
> Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
> Median age in Israel is 30.4yrs.
> Median age in Peru and Mexico is 27.5yrs.
> Median age in India is 26.8yrs.
> Median age in South Africa is 25yrs.
>
>
> Comparison charts, as of Apr 30 are available:
> http://ve3ute.ca/query/210430_cases_ppm_major.jpg
> http://ve3ute.ca/query/210430_cases_ppm_report_group.jpg
> http://ve3ute.ca/query/210430_deaths_daily_ppm_report_group.jpg
> http://ve3ute.ca/query/210430_deaths_ppm_report_group.jpg
> http://ve3ute.ca/query/210430_vaccinations_report_group.jpg
> http://ve3ute.ca/query/210430_vaccinations_major.jpg
>
>
>
> Flu Season? Fatality comparison in the U.S.A.
> http://ve3ute.ca/query/flu_season_020.jpg
> Updated Apr30
>

Israel, with >120% of vaccine doses applied to vaccinate 59% of
the population, reports a daily virus detection rate below 10ppm
and a 0.2ppm/day fatality rate. These figures have not altered
significantly in the last 30 days - indicating the end of
Pfizer's vaccination trial.

The US, UK and Chile have all issued >80% of vaccine doses, with
vaccination rates of 37%, 30% and 39% respectively. Detection
and fatality rates, however, do not correlate:
- The UK has achieved detection and fatality rates comparable to
those of Israel, which benefits from 2x their vaccination levels.
- The US has only achieved detection and fatalty rates comparable
to the EEC, which benefits from < 1/3 of their vaccination levels.
- Chile seems to have benefited only in that it's fatality rates
are reduced from those of its unvaccinated neighbour, Peru.
Detection rates in Chile are actually rising.

As of May17:
US detections are at 99518ppm.(10.0%)
Detection rate is 106ppm/day and falling.
Fatalities are 1770ppm at 1.8ppm/day
FR is 1.8% from a 98927ppm detection recorded 7 days previously.
US tests total 1298960ppm (130%) at 2484ppm/day
7.7% of tests are positive - currently 4.3%.
Vaccinations at 817900ppm (81.8%) with 36.9% vaccinated.

Canada detections at 35392ppm (3.5%) ~ 179 days behind the US.
Detection rate at 160ppm/day and falling.
Fatalities are 660ppm at 1.2ppm/day.
FR is 1.9% from a 34510ppm detection recorded 7 days previously.
Canada tests total 877800ppm (88%) at 3270ppm/day
4.0% of tests are positive - currently 4.9%.
Vaccinations at 487900ppm (48.7%) with 3.7% vaccinated.

Italian detections at 68789ppm. (6.9%)
Detection rate is 113ppm/day and falling.
Fatalities are 2053ppm at 3.1ppm/day.
FR is 3.0% from a 68081ppm detection recorded 7 days previously.
Italian tests total 1027210ppm (103%) - at 4500ppm/day.
6.7% of tests are positive - currently 2.5%.
Vaccinations at 453400ppm (45.3%) with 14.3% vaccinated.

Sweden detections at 102693ppm. (10.2%)
Detection rate is 413ppm/day and falling.
Fatalities are 1413ppm at 1.4ppm/day.
FR is 1.4% from a 100756ppm detection recorded 7 days previously.
Sweden tests performed are unreported at ~5060ppm/day
No test positivity rate is possible - currently 8.2%
Vaccinations at 413700ppm (41.4%) with 9.7% vaccinated.

UK detections at 65795ppm. (6.6%)
Detection rate is 34ppm/day and leveling below 40ppm/day.
Fatalities are 1885ppm at 0.2ppm/day.
FR is 2.9% from a 65595ppm detection recorded 7 days previously.
UK tests total 2435880ppm (244%) at 14730ppm/day.
2.7% of tests are positive - currently 0.2%.
Vaccinations at 834900ppm (83.5%) with 29.6% vaccinated

Brazil detections at 73519ppm. (7.4%)
Detection rate is 297ppm/day and rising.
Fatalities are 2050ppm at 9.0ppm/day.
FR is 2.9% from a 71556ppm detection recorded 7 days previously.
Brazil tests performed are unreported.
No test positivity rate is possible.
Vaccinations at 248300ppm (24.8%) with 8.0% vaccinated.

Peru detections at 57293ppm (5.7%)
Detection rate is 168ppm/day and possibly leveling below 200ppm/day.
Fatalities are 2008ppm at 9.2ppm/day.
FR is 3.6% from a 56117ppm detection recorded 7 days previously.
Peru tests performed are unreported.
No test positivity rate is possible.
Vaccinations at 76200ppm (7.6%) with 2.4% vaccinated

Chile detections at 67301ppm (6.7%)
Detection rate is 292ppm/day and rising.
Fatalities are 1456ppm at 4.6ppm/day.
FR is 2.3% from a 63601ppm detection recorded 14 days previously.
Chile tests performed 719300ppm (72%) - at 2870ppm/day.
9.4% of tests are positive - currently 10.2%.
Vaccinations at 866800ppm (86.7%) with 39.2% vaccinated.

Argentina detections at 73177ppm (7.3%)
Detection rate is 504ppm/day and rising.
Fatalities are 1560ppm at 10.1ppm/day.
FR is 2.2% from a 70031ppm detection recorded 7 days previously.
Argentina tests performed total 202250ppm (20%) at 670ppm/day.
36% of tests are positive - currently 75%.
Vaccinations at 218700ppm (21.9%) with 4.2% vaccinated.

Mexico detections at 18474ppm (1.8%)
Detection rate is 18ppm/day and leveling below 30ppm/day.
Fatalities are 1710ppm at 1.6ppm/day.
FR is 9.3% from a 18355ppm detection recorded 7 days previously.
Mexico tests performed total 49440ppm (4.9%), at 70ppm/day.
38% of tests are positive - currently 26%.
Vaccinations at 179700ppm (18.0%) with 8.2% vaccinated.

South Africa detections at 27209ppm (2.7%)
Detection rate is 41ppm/day and rising.
Fatalities are 931ppm at 1.10ppm/day.
FR is 3.5% from a 26939ppm detection recorded 7 days previously.
SA tests performed total 185660ppm (18.6%) at 490ppm/day.
14.7% of tests are positive - currently 8.4%.
Vaccinations at 8100ppm (0.8%) with 0.8% vaccinated.

Czech detections at 154341ppm (15.4%)
Detection rate is 104ppm/day and falling.
Fatalities are 2792ppm at 3.1ppm/day.
FR is 1.8% from a 153651ppm detection recorded 7 days previously.
Czech tests are unreported, at 15910ppm/day.
No test positivity rate is possible - currently 0.7%.
Vaccinations at 386500ppm (38.7%) with 10.3% vaccinated.

India detections at 18091ppm (1.8%)
Detection rate is 239ppm/day and falling.
Fatalities at 199ppm at 2.9ppm/day.
FR is 1.2% from a 16661ppm detection recorded 7 days previously.
Indian tests performed total 224240ppm (22%) at 1310ppm/day.
8.1% of tests are positive - currently 18.2%.
Vaccinations at 132100ppm (13.2%) with 2.9% vaccinated.

Israel detections at 96946ppm (9.7%)
Detection rate is 4ppm/day and leveling below 10ppm/day
Fatalities at 737ppm at 0.1ppm/day.
FR is 0.8% from a 96927ppm detection recorded 7 days previously.
Israeli tests performed total 1909480ppm (191%) at 3330ppm/day.
5.1% of tests are positive - currently 0.1%
Vaccinations at 1216500ppm (122%) with 58.9% vaccinated.

>
> Chile participated in Phase 3 trials for AstraZeneca,
> Johnson & Johnson, Sinovac and CanSino. Chile has contracts
> with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
> Sinovac is their regular supplier of seasonal flu vaccine.
> Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
> temperatures. About 60% of Chile's contracted 80 million doses
> are from Sinovac.
>
> Chile maintains a Public Health service database that includes
> regular vaccination scheduling. Using these resources alone
> allowed vaccination rates as high as 1 million doses per week
> to be delivered as early as mid-February. Approval of vaccine
> use was based on published Phase 1 and Phase 2 reporting.
>
> multiply ppm by population (in millions) for real numbers.
> China - 1397 million
> Iceland - 0.36 million
> US - 330 million
> Canada - 37 million
> Italy - 60 million
> Sweden - 10 million
> UK - 66 million
> Brazil - 210 million
> Peru - 32 million
> Chile - 19 million
> Argentina - 45 million
> Mexico - 127 million
> South Africa - 58 million
> Czech Republic - 10.7 million
> Israel - 10 million
> India - 1391 million

RL

> Per capita comparisons are interesting, as they represent
> efforts, within political boundaries, equally.
> Data is easily obtained by visiting the data explorer page
> at Our World in Data:

> http://tiny.cc/ul41tz

>
> A 100ppm daily detection rate would, in one year, result in
> an approximately 4% penetration within the population.
>
> Testing of blood donor samples in Quebec suggests that covid-19
> antibodies are present in the local population at 3x positive
> virus detection test rate.
>
> Median age in Germany and Italy is 45-46yrs.
> Median age in Canada, UK and Sweden is 40-41yrs.
> Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively.
> Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
> Median age in Israel is 30.4yrs.
> Median age in Peru and Mexico is 27.5yrs.
> Median age in India is 26.8yrs.
> Median age in South Africa is 25yrs.
>
>
> Comparison charts, as of Apr 30 are available:
> http://ve3ute.ca/query/210430_cases_ppm_major.jpg
> http://ve3ute.ca/query/210430_cases_ppm_report_group.jpg
> http://ve3ute.ca/query/210430_deaths_daily_ppm_report_group.jpg
> http://ve3ute.ca/query/210430_deaths_ppm_report_group.jpg
> http://ve3ute.ca/query/210430_vaccinations_report_group.jpg
> http://ve3ute.ca/query/210430_vaccinations_major.jpg
>
>
>
> Flu Season? Fatality comparison in the U.S.A.
> http://ve3ute.ca/query/flu_season_020.jpg
> Updated Apr30
>

Israel, with >120% of vaccine doses applied to vaccinate 59% of
the population, reports a daily virus detection rate below 10ppm
and a 0.3ppm/day fatality rate. These figures have not altered
significantly in the last 30 days - indicating the end of
Pfizer's vaccination trial.

The US, UK and Chile have all issued >80% of vaccine doses, with
vaccination rates of 37%, 30% and 39% respectively. Detection
and fatality rates, however, do not correlate:
- The UK has achieved detection and fatality rates comparable to
those of Israel, which benefits from 2x their vaccination levels.
- The US has only achieved detection and fatalty rates comparable
to the EEC, which benefits from < 1/3 of their vaccination levels.
- Chile seems to have benefited only in that it's fatality rates
are reduced from those of its unvaccinated neighbour, Peru.
Detection rates in Chile are actually rising.

As of May20:
US detections are at 99778ppm.(10.0%)
Detection rate is 91ppm/day and falling.
Fatalities are 1776ppm at 1.7ppm/day
FR is 1.8% from a 99253ppm detection recorded 7 days previously.
US tests total 1309870ppm (131%) at 2170ppm/day
7.6% of tests are positive - currently 4.2%.
Vaccinations at 829100ppm (82.9%) with 37.5% vaccinated.

Canada detections at 35793ppm (3.6%) ~ 182 days behind the US.
Detection rate at 138ppm/day and falling.
Fatalities are 664ppm at 1.1ppm/day.
FR is 1.9% from a 34980ppm detection recorded 7 days previously.
Canada tests total 887130ppm (89%) at 3120ppm/day
4.0% of tests are positive - currently 4.4%.
Vaccinations at 515200ppm (51.5%) with 3.9% vaccinated.

Italian detections at 69011ppm. (6.9%)
Detection rate is 98ppm/day and falling.
Fatalities are 2062ppm at 2.6ppm/day.
FR is 3.0% from a 68459ppm detection recorded 7 days previously.
Italian tests total 1040370ppm (104%) - at 4270ppm/day.
6.6% of tests are positive - currently 2.3%.
Vaccinations at 477300ppm (47.7%) with 15.3% vaccinated.

Sweden detections at 104142ppm. (10.4%)
Detection rate is 337ppm/day and falling.
Fatalities are 1421ppm at 1.2ppm/day.
FR is 1.4% from a 101783ppm detection recorded 7 days previously.
Sweden tests performed are unreported at ~5060ppm/day
No test positivity rate is possible - currently 6.7%
Vaccinations at 431900ppm (43.2%) with 10.2% vaccinated.

UK detections at 65822ppm. (6.6%)
Detection rate is 22ppm/day and leveling below 40ppm/day.
Fatalities are 1885ppm at 0.1ppm/day.
FR is 2.9% from a 65702ppm detection recorded 7 days previously.
UK tests total 2450930ppm (245%) at 8750ppm/day.
2.7% of tests are positive - currently 0.3%.
Vaccinations at 852300ppm (85.2%) with 30.7% vaccinated

Brazil detections at 74389ppm. (7.4%)
Detection rate is 304ppm/day and rising.
Fatalities are 2078ppm at 9.2ppm/day.
FR is 2.9% from a 72610ppm detection recorded 7 days previously.
Brazil tests performed are unreported.
No test positivity rate is possible.
Vaccinations at 259200ppm (25.9%) with 8.3% vaccinated.

Peru detections at 57735ppm (5.8%)
Detection rate is 165ppm/day and possibly leveling below 190ppm/day.
Fatalities are 2033ppm at 9.3ppm/day.
FR is 3.6% from a 56583ppm detection recorded 7 days previously.
Peru tests performed are unreported.
No test positivity rate is possible.
Vaccinations at 82000ppm (8.2%) with 2.5% vaccinated

Chile detections at 68038ppm (6.8%)
Detection rate is 300ppm/day and rising.
Fatalities are 1465ppm at 4.6ppm/day.
FR is 2.3% from a 64304ppm detection recorded 14 days previously.
Chile tests performed 729610ppm (73%) - at 2920ppm/day.
9.3% of tests are positive - currently 10.3%.
Vaccinations at 885000ppm (88.5%) with 39.7% vaccinated.

Argentina detections at 75475ppm (7.5%)
Detection rate is 618ppm/day and rising to levels previously unseen.
Fatalities are 1599ppm at 10.9ppm/day.
FR is 2.2% from a 71735ppm detection recorded 7 days previously.
Argentina tests performed total 202790ppm (20%) at 700ppm/day.
37% of tests are positive - currently 88%.
Vaccinations at 229800ppm (23.0%) with 4.7% vaccinated.

Mexico detections at 18518ppm (1.9%)
Detection rate is 18ppm/day and leveling below 30ppm/day.
Fatalities are 1713ppm at 1.4ppm/day.
FR is 9.3% from a 18421ppm detection recorded 7 days previously.
Mexico tests performed total 49770ppm (5.0%), at 70ppm/day.
37% of tests are positive - currently 26%.
Vaccinations at 187900ppm (18.8%) with 8.3% vaccinated.

South Africa detections at 27338ppm (2.7%)
Detection rate is 47ppm/day and rising.
Fatalities are 936ppm at 1.3ppm/day.
FR is 3.5% from a 27066ppm detection recorded 7 days previously.
SA tests performed total 187410ppm (18.7%) at 550ppm/day.
14.6% of tests are positive - currently 8.5%.
Vaccinations at 9400ppm (0.9%) with 0.9% vaccinated.

Czech detections at 154582ppm (15.4%)
Detection rate is 90ppm/day and falling.
Fatalities are 2797ppm at 2.2ppm/day.
FR is 1.8% from a 154071ppm detection recorded 7 days previously.
Czech tests are unreported, at 16850ppm/day.
No test positivity rate is possible - currently 0.5%.
Vaccinations at 409800ppm (41.0%) with 10.6% vaccinated.

India detections at 18676ppm (1.9%)
Detection rate is 214ppm/day and falling.
Fatalities at 208ppm at 3.0ppm/day.
FR is 1.2% from a 17425ppm detection recorded 7 days previously.
Indian tests performed total 226820ppm (23%) at 1300ppm/day.
8.2% of tests are positive - currently 16.5%.
Vaccinations at 135100ppm (13.5%) with 3.0% vaccinated.

Israel detections at 96958ppm (9.7%)
Detection rate is 3ppm/day and leveling below 10ppm/day
Fatalities at 739ppm at 0.3ppm/day.
FR is 0.8% from a 96939ppm detection recorded 7 days previously.
Israeli tests performed total 1913370ppm (191%) at 2690ppm/day.
5.1% of tests are positive - currently 0.1%
Vaccinations at 1218100ppm (122%) with 59.0% vaccinated.

>
> Chile participated in Phase 3 trials for AstraZeneca,
> Johnson & Johnson, Sinovac and CanSino. Chile has contracts
> with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
> Sinovac is their regular supplier of seasonal flu vaccine.
> Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
> temperatures. About 60% of Chile's contracted 80 million doses
> are from Sinovac.
>
> Chile maintains a Public Health service database that includes
> regular vaccination scheduling. Using these resources alone
> allowed vaccination rates as high as 1 million doses per week
> to be delivered as early as mid-February. Approval of vaccine
> use was based on published Phase 1 and Phase 2 reporting.
>
> multiply ppm by population (in millions) for real numbers.
> China - 1397 million
> Iceland - 0.36 million
> US - 330 million
> Canada - 37 million
> Italy - 60 million
> Sweden - 10 million
> UK - 66 million
> Brazil - 210 million
> Peru - 32 million
> Chile - 19 million
> Argentina - 45 million
> Mexico - 127 million
> South Africa - 58 million
> Czech Republic - 10.7 million
> Israel - 10 million
> India - 1391 million

RL

> Per capita comparisons are interesting, as they represent
> efforts, within political boundaries, equally.
> Data is easily obtained by visiting the data explorer page
> at Our World in Data:

> http://tiny.cc/ul41tz

>
> A 100ppm daily detection rate would, in one year, result in
> an approximately 4% penetration within the population.
>
> Testing of blood donor samples in Quebec suggests that covid-19
> antibodies are present in the local population at 3x positive
> virus detection test rate.
>
> Median age in Germany and Italy is 45-46yrs.
> Median age in Canada, UK and Sweden is 40-41yrs.
> Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively.
> Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
> Median age in Israel is 30.4yrs.
> Median age in Peru and Mexico is 27.5yrs.
> Median age in India is 26.8yrs.
> Median age in South Africa is 25yrs.
>
>
> Comparison charts, as of Apr 30 are available:
> http://ve3ute.ca/query/210430_cases_ppm_major.jpg
> http://ve3ute.ca/query/210430_cases_ppm_report_group.jpg
> http://ve3ute.ca/query/210430_deaths_daily_ppm_report_group.jpg
> http://ve3ute.ca/query/210430_deaths_ppm_report_group.jpg
> http://ve3ute.ca/query/210430_vaccinations_report_group.jpg
> http://ve3ute.ca/query/210430_vaccinations_major.jpg
>
>
>
> Flu Season? Fatality comparison in the U.S.A.
> http://ve3ute.ca/query/flu_season_020.jpg
> Updated Apr30
>

Israel, with >120% of vaccine doses applied to vaccinate 59% of
the population, reports a daily virus detection rate below 10ppm
and a 0.4ppm/day fatality rate. These figures have not altered
significantly in the last 30 days - indicating the end of
Pfizer's vaccination trial.

The US, UK and Chile have all issued >80% of vaccine doses, with
vaccination rates of 39%, 33% and 40% respectively. Detection
and fatality rates, however, do not correlate:
- The UK has achieved detection and fatality rates comparable to
those of Israel, which benefits from 2x their vaccination levels.
- The US has only achieved detection and fatalty rates comparable
to the EEC, which benefits from < 1/3 of their vaccination levels.
- Chile seems to have benefited only in that it's fatality rates
are reduced from those of its unvaccinated neighbour, Peru.
Detection rates in Chile are actually rising.

As of May24:
US detections are at 100053ppm.(10.0%)
Detection rate is 76ppm/day and falling.
Fatalities are 1782ppm at 1.6ppm/day
FR is 1.8% from a 99605ppm detection recorded 7 days previously.
US tests total 1322050ppm (132%) at 2270ppm/day
7.6% of tests are positive - currently 3.3%.
Vaccinations at 854300ppm (85.4%) with 38.9% vaccinated.

Canada detections at 36206ppm (3.6%) ~ 185 days behind the US.
Detection rate at 116ppm/day and falling.
Fatalities are 668ppm at 1.1ppm/day.
FR is 1.9% from a 35563ppm detection recorded 7 days previously.
Canada tests total 897240ppm (90%) at 2780ppm/day
4.0% of tests are positive - currently 4.2%.
Vaccinations at 557100ppm (55.7%) with 4.4% vaccinated.

Italian detections at 69336ppm. (6.9%)
Detection rate is 78ppm/day and falling.
Fatalities are 2071ppm at 2.5ppm/day.
FR is 3.0% from a 68847ppm detection recorded 7 days previously.
Italian tests total 1055590ppm (104%) - at 4050ppm/day.
6.6% of tests are positive - currently 1.9%.
Vaccinations at 511100ppm (51.1%) with 16.9% vaccinated.

Sweden detections at 104794ppm. (10.5%)
Detection rate is 300ppm/day and falling.
Fatalities are 1422ppm at 1.3ppm/day.
FR is 1.4% from a 102693ppm detection recorded 7 days previously.
Sweden tests performed are unreported at ~4050ppm/day
No test positivity rate is possible - currently 7.4%
Vaccinations at 449900ppm (45.0%) with 11.0% vaccinated.

UK detections at 65969ppm. (6.6%)
Detection rate is 25ppm/day and leveling below 40ppm/day.
Fatalities are 1885ppm at 0.1ppm/day.
FR is 2.9% from a 65825ppm detection recorded 7 days previously.
UK tests total 2498820ppm (250%) at 8990ppm/day.
2.6% of tests are positive - currently 0.3%.
Vaccinations at 892500ppm (89.3%) with 33.4% vaccinated

Brazil detections at 75665ppm. (7.6%)
Detection rate is 306ppm/day and rising.
Fatalities are 2113ppm at 9.0ppm/day.
FR is 2.9% from a 73661ppm detection recorded 7 days previously.
Brazil tests performed are unreported.
No test positivity rate is possible.
Vaccinations at 271700ppm (27.2%) with 8.7% vaccinated.

Peru detections at 58392ppm (5.8%)
Detection rate is 157ppm/day and possibly leveling below 170ppm/day.
Fatalities are 2064ppm at 7.9ppm/day.
FR is 3.6% from a 57293ppm detection recorded 7 days previously.
Peru tests performed are unreported.
No test positivity rate is possible.
Vaccinations at 94600ppm (9.4%) with 2.8% vaccinated

Chile detections at 69570ppm (7.0%)
Detection rate is 324ppm/day and rising.
Fatalities are 1492ppm at 5.1ppm/day.
FR is 2.3% from a 65536ppm detection recorded 14 days previously.
Chile tests performed 739950ppm (74%) - at 2950ppm/day.
9.3% of tests are positive - currently 11.0%.
Vaccinations at 906000ppm (90.6%) with 40.3% vaccinated.

Argentina detections at 78314ppm (7.8%)
Detection rate is 734ppm/day and rising to levels previously unseen.
Fatalities are 1639ppm at 11.2ppm/day.
FR is 2.2% from a 73811ppm detection recorded 7 days previously.
Argentina tests performed total 206940ppm (21%) at 750ppm/day.
No test positivity rate is possible
Vaccinations at 244900ppm (24.5%) with 5.2% vaccinated.

Mexico detections at 18588ppm (1.9%)
Detection rate is 16ppm/day and leveling below 30ppm/day.
Fatalities are 1719ppm at 1.3ppm/day.
FR is 9.3% from a 18481ppm detection recorded 7 days previously.
Mexico tests performed total 50160ppm (5.0%), at 70ppm/day.
37% of tests are positive - currently 23%.
Vaccinations at 205400ppm (20.5%) with 9.2% vaccinated.

South Africa detections at 27575ppm (2.8%)
Detection rate is 52ppm/day and rising.
Fatalities are 941ppm at 1.4ppm/day.
FR is 3.5% from a 27239ppm detection recorded 7 days previously.
SA tests performed total 189630ppm (19.0%) at 570ppm/day.
14.6% of tests are positive - currently 9.1%.
Vaccinations at 10900ppm (1.1%) with 0.8% vaccinated.

Czech detections at 154813ppm (15.5%)
Detection rate is 67ppm/day and falling.
Fatalities are 2803ppm at 1.6ppm/day.
FR is 1.8% from a 154366ppm detection recorded 7 days previously.
Czech tests are unreported, at 17640ppm/day.
No test positivity rate is possible - currently 0.4%.
Vaccinations at 435000ppm (43.5%) with 11.3% vaccinated.

India detections at 19386ppm (1.9%)
Detection rate is 185ppm/day and falling.
Fatalities at 220ppm at 3.0ppm/day.
FR is 1.2% from a 18282ppm detection recorded 7 days previously.
Indian tests performed total 235090ppm (24%) at 1350ppm/day.
8.2% of tests are positive - currently 13.7%.
Vaccinations at 138900ppm (13.9%) with 3.0% vaccinated.

Israel detections at 96969ppm (9.7%)
Detection rate is 3ppm/day and leveling below 10ppm/day
Fatalities at 740ppm at 0.4ppm/day.
FR is 0.8% from a 96951ppm detection recorded 7 days previously.
Israeli tests performed total 1925840ppm (193%) at 2330ppm/day.
5.0% of tests are positive - currently 0.1%
Vaccinations at 1219800ppm (122%) with 59.1% vaccinated.

>
> Chile participated in Phase 3 trials for AstraZeneca,
> Johnson & Johnson, Sinovac and CanSino. Chile has contracts
> with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
> Sinovac is their regular supplier of seasonal flu vaccine.
> Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
> temperatures. About 60% of Chile's contracted 80 million doses
> are from Sinovac.
>
> Chile maintains a Public Health service database that includes
> regular vaccination scheduling. Using these resources alone
> allowed vaccination rates as high as 1 million doses per week
> to be delivered as early as mid-February. Approval of vaccine
> use was based on published Phase 1 and Phase 2 reporting.
>
> multiply ppm by population (in millions) for real numbers.
> China - 1397 million
> Iceland - 0.36 million
> US - 330 million
> Canada - 37 million
> Italy - 60 million
> Sweden - 10 million
> UK - 66 million
> Brazil - 210 million
> Peru - 32 million
> Chile - 19 million
> Argentina - 45 million
> Mexico - 127 million
> South Africa - 58 million
> Czech Republic - 10.7 million
> Israel - 10 million
> India - 1391 million

RL

> Per capita comparisons are interesting, as they represent
> efforts, within political boundaries, equally.
> Data is easily obtained by visiting the data explorer page
> at Our World in Data:

> http://tiny.cc/ul41tz

>
> A 100ppm daily detection rate would, in one year, result in
> an approximately 4% penetration within the population.
>
> Testing of blood donor samples in Quebec suggests that covid-19
> antibodies are present in the local population at 3x positive
> virus detection test rate.
>
> Median age in Germany and Italy is 45-46yrs.
> Median age in Canada, UK and Sweden is 40-41yrs.
> Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively.
> Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
> Median age in Israel is 30.4yrs.
> Median age in Peru and Mexico is 27.5yrs.
> Median age in India is 26.8yrs.
> Median age in South Africa is 25yrs.
>
>
> Comparison charts, as of Apr 30 are available:
> http://ve3ute.ca/query/210430_cases_ppm_major.jpg
> http://ve3ute.ca/query/210430_cases_ppm_report_group.jpg
> http://ve3ute.ca/query/210430_deaths_daily_ppm_report_group.jpg
> http://ve3ute.ca/query/210430_deaths_ppm_report_group.jpg
> http://ve3ute.ca/query/210430_vaccinations_report_group.jpg
> http://ve3ute.ca/query/210430_vaccinations_major.jpg
>
>
>
> Flu Season? Fatality comparison in the U.S.A.
> http://ve3ute.ca/query/flu_season_020.jpg
> Updated Apr30
>

Israel, with >120% of vaccine doses applied to vaccinate 59% of
the population, reports a daily virus detection rate below 10ppm
and a 0.2ppm/day fatality rate. These figures have not altered
significantly in the last 30 days - indicating the end of
Pfizer's vaccination trial.

The US, UK and Chile have all issued >85% of vaccine doses, with
vaccination rates of 39%, 35% and 41% respectively. Detection
and fatality rates, however, do not correlate:
- The UK has achieved detection and fatality rates comparable to
those of Israel, which benefits from 2x their vaccination levels.
- The US has only achieved detection and fatalty rates comparable
to the EEC, which benefits from < 1/3 of their vaccination levels.
- Chile seems to have benefited only in that it's fatality rates
are reduced from those of its unvaccinated neighbours, Peru and
Argentina. Detection rates in Chile have risen consistently for
the last 3 weeks.

As of May27:
US detections are at 100273ppm.(10.0%)
Detection rate is 71ppm/day and falling.
Fatalities are 1788ppm at 1.7ppm/day
FR is 1.8% from a 99869ppm detection recorded 7 days previously.
US test rate is 2270ppm/day
3.1%% of current tests are positive.
Vaccinations at 864800ppm (86.5%) with 39.4% fully vaccinated.

Canada detections at 36412ppm (3.6%) ~ 188 days behind the US.
Detection rate at 89ppm/day and falling.
Fatalities are 670ppm at 1.0ppm/day.
FR is 1.9% from a 35921ppm detection recorded 7 days previously.
Canada test rate is 2340ppm/day
3.8% of current tests are positive.
Vaccinations at 581300ppm (58.1%) with 4.6% fully vaccinated.

Italy detections at 69496ppm. (6.9%)
Detection rate is 69ppm/day and falling.
Fatalities are 2078ppm at 2.3ppm/day.
FR is 3.0% from a 69106ppm detection recorded 7 days previously.
Italy test rate is 3800ppm/day.
1.8% of current tests are positive.
Vaccinations at 535400ppm (53.5%) with 18.0% fully vaccinated.

Sweden detections at 105667ppm. (10.6%)
Detection rate is 217ppm/day and falling.
Fatalities are 1429ppm at 1.2ppm/day.
FR is 1.4% from a 104480ppm detection recorded 7 days previously.
Sweden test rate is 3710ppm/day.
5.5% of current tests are positive.
Vaccinations at 477400ppm (47.7%) with 12.2% vaccinated.

UK detections at 66084ppm. (6.6%)
Detection rate is 37ppm/day and leveling below 40ppm/day.
Fatalities are 1886ppm at 0.1ppm/day.
FR is 2.9% from a 65861ppm detection recorded 7 days previously.
UK test rate is 14320ppm/day.
0.3% of current tests are positive.
Vaccinations at 913200ppm (91.3%) with 34.8% vaccinated

Brazil detections at 76565ppm. (7.7%)
Detection rate is 311ppm/day and rising.
Fatalities are 2138ppm at 8.6ppm/day.
FR is 2.9% from a 74389ppm detection recorded 7 days previously.
Brazil test rate is unreported.
No test positivity rate is possible.
Vaccinations at 303800ppm (30.4%) with 10.0% vaccinated.

Peru detections at 58755ppm (5.9%)
Detection rate is 146ppm/day and possibly leveling below 160ppm/day.
Fatalities are 2082ppm at 6.9ppm/day.
FR is 3.7% from a 57735ppm detection recorded 7 days previously.
Peru tests performed are unreported.
No test positivity rate is possible.
Vaccinations at 102400ppm (10.4%) with 3.1% vaccinated

Chile detections at 70339ppm (7.0%)
Detection rate is 329ppm/day and rising.
Fatalities are 1497ppm at 4.7ppm/day.
FR is 2.3% from a 66258ppm detection recorded 14 days previously.
Chile test rate is 2860ppm/day.
11.5% of current tests are positive.
Vaccinations at 930900ppm (93.1%) with 40.9% vaccinated.

Argentina detections at 80143ppm (8.0%)
Detection rate is 667ppm/day and posibly leveling below 680ppm/day.
Fatalities are 1672ppm at 10.5ppm/day.
FR is 2.2% from a 76269ppm detection recorded 7 days previously.
Argentina test rate is 870ppm/day.
Test positivity values are impractical.
Vaccinations at 250700ppm (25.1%) with 5.4% vaccinated.

Mexico detections at 18635ppm (1.9%)
Detection rate is 17ppm/day and leveling below 30ppm/day.
Fatalities are 1724ppm at 1.5ppm/day.
FR is 9.3% from a 18539ppm detection recorded 7 days previously.
Mexico test rate is 70ppm/day.
Test positivity values are impractical.
Vaccinations at 214900ppm (21.5%) with 9.2% vaccinated.

South Africa detections at 27616ppm (2.8%)
Detection rate is 40ppm/day and falling.
Fatalities are 949ppm at 1.1ppm/day.
FR is 3.5% from a 27399ppm detection recorded 7 days previously.
SA test rate is 580ppm/day.
6.9% of current tests are positive.
Vaccinations at 11800ppm (1.2%) with 0.8% vaccinated.

Czech detections at 154957ppm (15.5%)
Detection rate is 54ppm/day and falling.
Fatalities are 2806ppm at 1.4ppm/day.
FR is 1.8% from a 154655ppm detection recorded 7 days previously.
Czech test rate is 16900ppm/day.
0.3% of current tests are positive.
Vaccinations at 459900ppm (46.0%) with 12.3% vaccinated.

India detections at 19833ppm (2.0%)
Detection rate is 165ppm/day and falling.
Fatalities at 228ppm at 2.9ppm/day.
FR is 1.2% from a 18864ppm detection recorded 7 days previously.
India test rate 1500ppm/day.
11.0% of current tests are positive.
Vaccinations at 143800ppm (14.4%) with 3.1% vaccinated.

Israel detections at 96979ppm (9.7%)
Detection rate is 3ppm/day and leveling below 10ppm/day
Fatalities at 740ppm at 0.2ppm/day.
FR is 0.8% from a 96938ppm detection recorded 7 days previously.
Israel test rate is 2930ppm/day.
0.1% of current tests are positive
Vaccinations at 1221800ppm (122%) with 59.2% vaccinated.

>
> Chile participated in Phase 3 trials for AstraZeneca,
> Johnson & Johnson, Sinovac and CanSino. Chile has contracts
> with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
> Sinovac is their regular supplier of seasonal flu vaccine.
> Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
> temperatures. About 60% of Chile's contracted 80 million doses
> are from Sinovac.
>
> Chile maintains a Public Health service database that includes
> regular vaccination scheduling. Using these resources alone
> allowed vaccination rates as high as 1 million doses per week
> to be delivered as early as mid-February. Approval of vaccine
> use was based on published Phase 1 and Phase 2 reporting.
>
> multiply ppm by population (in millions) for real numbers.
> China - 1397 million
> Iceland - 0.36 million
> US - 330 million
> Canada - 37 million
> Italy - 60 million
> Sweden - 10 million
> UK - 66 million
> Brazil - 210 million
> Peru - 32 million
> Chile - 19 million
> Argentina - 45 million
> Mexico - 127 million
> South Africa - 58 million
> Czech Republic - 10.7 million
> Israel - 10 million
> India - 1391 million

RL

> Per capita comparisons are interesting, as they represent
> efforts, within political boundaries, equally.
> Data is easily obtained by visiting the data explorer page
> at Our World in Data:

> http://tiny.cc/ul41tz

>
> A 100ppm daily detection rate would, in one year, result in
> an approximately 4% penetration within the population.
>
> Testing of blood donor samples in Quebec suggests that covid-19
> antibodies are present in the local population at 3x positive
> virus detection test rate.
>
> Median age in Germany and Italy is 45-46yrs.
> Median age in Canada, UK and Sweden is 40-41yrs.
> Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively.
> Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
> Median age in Israel is 30.4yrs.
> Median age in Peru and Mexico is 27.5yrs.
> Median age in India is 26.8yrs.
> Median age in South Africa is 25yrs.
>
>
Comparison charts, as of Apr 30 are available:
http://ve3ute.ca/query/210531_cases_ppm_major.jpg
http://ve3ute.ca/query/210531_cases_ppm_report_group.jpg
http://ve3ute.ca/query/210531_deaths_daily_ppm_report_group.jpg
http://ve3ute.ca/query/210531_deaths_ppm_report_group.jpg
http://ve3ute.ca/query/210531_vaccine_doses_report_group.jpg
http://ve3ute.ca/query/210531_vaccinations_completed_report_group.jpg
>
>
>
Flu Season? Fatality comparison in the U.S.A.
http://ve3ute.ca/query/flu_season_021.jpg
Updated May31
>

> Israel, with >120% of vaccine doses applied to vaccinate 59% of
> the population, reports a daily virus detection rate below 10ppm
> and a 0.2ppm/day fatality rate. These figures have not altered
> significantly in the last 30 days - indicating the end of
> Pfizer's vaccination trial.

The US, UK and Chile have all issued >85% of vaccine doses, with
vaccination rates of 39%, 35% and 41% respectively. Detection
and fatality rates, however, do not correlate:
- The UK has achieved detection and fatality rates comparable to
those of Israel, which benefits from 2x their vaccination levels.
- The US has only achieved detection and fatalty rates comparable
to the EEC, which benefits from < 1/3 of their vaccination levels.
- Chile seems to have benefited only in that it's fatality rates
are reduced from those of its unvaccinated neighbours, Peru and
Argentina. Detection rates in Chile have risen consistently for
the last 3 weeks.

- and what the hell is going on in Argentina, anyways?

As of May31:
US detections are at 100479ppm.(10.0%)
Detection rate is 61ppm/day and falling.
Fatalities are 1796ppm at 2.0ppm/day
FR is 1.8% from a 100131ppm detection recorded 7 days previously.
US test rate is 2010ppm/day
3.0%% of current tests are positive.
Vaccinations at 881900ppm (88.2%) with 40.4% fully vaccinated.

Canada detections at 36732ppm (3.7%) ~ 191 days behind the US.
Detection rate at 75ppm/day and falling.
Fatalities are 675ppm at 1.0ppm/day.
FR is 1.9% from a 36252ppm detection recorded 7 days previously.
Canada test rate is 2220ppm/day
3.4% of current tests are positive.
Vaccinations at 621900ppm (62.2%) with 5.3% fully vaccinated.

Italy detections at 69730ppm. (7.0%)
Detection rate is 56ppm/day and falling.
Fatalities are 2085ppm at 1.9ppm/day.
FR is 3.0% from a 69377ppm detection recorded 7 days previously.
Italy test rate is 3780ppm/day.
1.5% of current tests are positive.
Vaccinations at 570100ppm (57.0%) with 19.6% fully vaccinated.

Sweden detections at 105797ppm. (10.6%)
Detection rate is 143ppm/day and falling.
Fatalities are 1431ppm at 1.2ppm/day.
FR is 1.4% from a 104794ppm detection recorded 7 days previously.
Sweden test rate is 3770ppm/day.
3.8% of current tests are positive.
Vaccinations at 494800ppm (49.5%) with 13.4% vaccinated.

UK detections at 66287ppm. (6.6%)
Detection rate is 45ppm/day and rising.
Fatalities are 1886ppm at 0.1ppm/day.
FR is 2.9% from a 66004ppm detection recorded 7 days previously.
UK test rate is 14220ppm/day.
0.3% of current tests are positive.
Vaccinations at 951500ppm (95.2%) with 37.3% vaccinated

Brazil detections at 77696ppm. (7.8%)
Detection rate is 290ppm/day and possibly leveling below 300ppm/day.
Fatalities are 2173ppm at 8.6ppm/day.
FR is 2.9% from a 75841ppm detection recorded 7 days previously.
Brazil test rate is unreported.
No test positivity rate is possible.
Vaccinations at 315600ppm (31.6%) with 10.4% vaccinated.

Peru detections at 59067ppm (5.9%)
Detection rate is 96ppm/day and falling.
Fatalities are 2092ppm at 4.0ppm/day.
FR is 3.6% from a 58392ppm detection recorded 7 days previously.
Peru tests performed are unreported.
No test positivity rate is possible.
Vaccinations at 112000ppm (11.2%) with 3.3% vaccinated

Chile detections at 72060ppm (7.2%)
Detection rate is 356ppm/day and rising.
Fatalities are 1526ppm at 4.9ppm/day.
FR is 2.3% from a 67592ppm detection recorded 14 days previously.
Chile test rate is 2870ppm/day.
12.4% of current tests are positive.
Vaccinations at 965900ppm (96.6%) with 41.6% vaccinated.

Argentina detections at 83052ppm (8.3%)
Detection rate is 677ppm/day and posibly leveling below 680ppm/day.
Fatalities are 1714ppm at 10.7ppm/day.
FR is 2.2% from a 78816ppm detection recorded 7 days previously.
Argentina test rate is 900ppm/day.
Test positivity values are impractical.
Vaccinations at 268200ppm (26.8%) with 6.1% vaccinated.

Mexico detections at 18714ppm (1.9%)
Detection rate is 18ppm/day and leveling below 30ppm/day.
Fatalities are 1733ppm at 2.0ppm/day.
FR is 9.3% from a 18593ppm detection recorded 7 days previously.
Mexico test rate is 70ppm/day.
Test positivity values are impractical.
Vaccinations at 235000ppm (23.5%) with 9.6% vaccinated.

South Africa detections at 27973ppm (2.8%)
Detection rate is 57ppm/day and rising.
Fatalities are 950ppm at 1.4ppm/day.
FR is 3.4% from a 27616ppm detection recorded 7 days previously.
SA test rate is 590ppm/day.
9.7% of current tests are positive.
Vaccinations at 16300ppm (1.6%) with 0.8% vaccinated.

Czech detections at 155118ppm (15.5%)
Detection rate is 44ppm/day and falling.
Fatalities are 2811ppm at 1.1ppm/day.
FR is 1.8% from a 154532ppm detection recorded 7 days previously.
Czech test rate is 16490ppm/day.
0.3% of current tests are positive.
Vaccinations at 487300ppm (48.7%) with 13.5% vaccinated.

India detections at 20324ppm (2.0%)
Detection rate is 134ppm/day and falling.
Fatalities at 238ppm at 2.6ppm/day.
FR is 1.2% from a 19528ppm detection recorded 7 days previously.
India test rate 1510ppm/day.
8.9% of current tests are positive.
Vaccinations at 151200ppm (15.1%) with 3.1% vaccinated.

Israel detections at 96985ppm (9.7%)
Detection rate is 2ppm/day and leveling below 10ppm/day
Fatalities at 741ppm at 0.1ppm/day.
FR is 0.8% from a 96975ppm detection recorded 7 days previously.
Israel test rate is 3020ppm/day.
0.1% of current tests are positive
Vaccinations at 1222500ppm (122%) with 59.3% vaccinated.

>
> Chile participated in Phase 3 trials for AstraZeneca,
> Johnson & Johnson, Sinovac and CanSino. Chile has contracts
> with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
> Sinovac is their regular supplier of seasonal flu vaccine.
> Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
> temperatures. About 60% of Chile's contracted 80 million doses
> are from Sinovac.
>
> Chile maintains a Public Health service database that includes
> regular vaccination scheduling. Using these resources alone
> allowed vaccination rates as high as 1 million doses per week
> to be delivered as early as mid-February. Approval of vaccine
> use was based on published Phase 1 and Phase 2 reporting.
>
> multiply ppm by population (in millions) for real numbers.
> China - 1397 million
> Iceland - 0.36 million
> US - 330 million
> Canada - 37 million
> Italy - 60 million
> Sweden - 10 million
> UK - 66 million
> Brazil - 210 million
> Peru - 32 million
> Chile - 19 million
> Argentina - 45 million
> Mexico - 127 million
> South Africa - 58 million
> Czech Republic - 10.7 million
> Israel - 10 million
> India - 1391 million

RL

> Per capita comparisons are interesting, as they represent
> efforts, within political boundaries, equally.
> Data is easily obtained by visiting the data explorer page
> at Our World in Data:

> http://tiny.cc/ul41tz

>
> A 100ppm daily detection rate would, in one year, result in
> an approximately 4% penetration within the population.
>
> Testing of blood donor samples in Quebec suggests that covid-19
> antibodies are present in the local population at 3x positive
> virus detection test rate.
>
> Median age in Germany and Italy is 45-46yrs.
> Median age in Canada, UK and Sweden is 40-41yrs.
> Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively.
> Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
> Median age in Israel is 30.4yrs.
> Median age in Peru and Mexico is 27.5yrs.
> Median age in India is 26.8yrs.
> Median age in South Africa is 25yrs.
>
>
Comparison charts, as of May31 are available:
http://ve3ute.ca/query/210531_cases_ppm_major.jpg
http://ve3ute.ca/query/210531_cases_ppm_report_group.jpg
http://ve3ute.ca/query/210531_deaths_daily_ppm_report_group.jpg
http://ve3ute.ca/query/210531_deaths_ppm_report_group.jpg
http://ve3ute.ca/query/210531_vaccine_doses_report_group.jpg
http://ve3ute.ca/query/210531_vaccinations_completed_report_group.jpg
>
>
>
Flu Season? Fatality comparison in the U.S.A.
http://ve3ute.ca/query/flu_season_021.jpg
Updated May31
>

> Israel, with >120% of vaccine doses applied to vaccinate 59% of
> the population, reports a daily virus detection rate below 10ppm
> and a 0.2ppm/day fatality rate. These figures have not altered
> significantly in the last 30 days - indicating the end of
> Pfizer's vaccination trial.

The US, UK and Chile have all issued >85% of vaccine doses, with
vaccination rates of 39%, 35% and 41% respectively. Detection
and fatality rates, however, do not correlate:
- The UK has achieved detection and fatality rates comparable to
those of Israel, which benefits from 2x their vaccination levels.
- The US has only achieved detection and fatalty rates comparable
to the EEC, which benefits from < 1/3 of their vaccination levels.
- Chile seems to have benefited only in that it's fatality rates
are reduced from those of its unvaccinated neighbours, Peru and
Argentina. Detection rates in Chile have risen consistently for
the last 3 weeks.

- and what the hell is going on in Argentina, anyways?

As of Jun 03:
US detections are at 100626ppm.(10.0%)
Detection rate is 49ppm/day and falling.
Fatalities are 1800ppm at 1.6ppm/day
FR is 1.8% from a 100365ppm detection recorded 7 days previously.
US test rate is 1870ppm/day
2.6%% of current tests are positive.
Vaccinations at 887800ppm (88.8%) with 40.7% fully vaccinated.

Canada detections at 36913ppm (3.7%) ~ 195 days behind the US.
Detection rate at 72ppm/day and falling.
Fatalities are 678ppm at 1.1ppm/day.
FR is 1.9% from a 36537ppm detection recorded 7 days previously.
Canada test rate is 2160ppm/day
3.3% of current tests are positive.
Vaccinations at 649700ppm (65.0%) with 6.0% fully vaccinated.

Italy detections at 69849ppm. (7.0%)
Detection rate is 51ppm/day and falling.
Fatalities are 2089ppm at 1.6ppm/day.
FR is 3.0% from a 69564ppm detection recorded 7 days previously.
Italy test rate is 3560ppm/day.
1.4% of current tests are positive.
Vaccinations at 592400ppm (59.2%) with 20.5% fully vaccinated.

Sweden detections are unreported (~10.6%)
Detection rate is unreported.
Fatalities are unreported.
no fatality rate can be calculated.
Sweden test rate is 3770ppm/day.
No test positivity rate is possible.
Vaccinations at 524500ppm (52.5%) with 15.2% vaccinated.

UK detections at 66444ppm. (6.6%)
Detection rate is 51ppm/day and rising.
Fatalities are 1886ppm at 0.1ppm/day.
FR is 2.9% from a 66134ppm detection recorded 7 days previously.
UK test rate is 14130ppm/day.
0.3% of current tests are positive.
Vaccinations at 967200ppm (96.7%) with 38.4% vaccinated

Brazil detections at 78661ppm. (7.9%)
Detection rate is 299ppm/day and possibly leveling below 300ppm/day.
Fatalities are 2200ppm at 8.9ppm/day.
FR is 2.9% from a 76883ppm detection recorded 7 days previously.
Brazil test rate is unreported.
No test positivity rate is possible.
Vaccinations at 324200ppm (32.4%) with 10.6% vaccinated.

Peru detections at 59609ppm (6.0%)
Detection rate is 122ppm/day and possibly leveling below 130ppm/day.
Fatalities are 2103ppm at 3.6ppm/day.
FR is 3.6% from a 58900ppm detection recorded 7 days previously.
Peru tests performed are unreported.
No test positivity rate is possible.
Vaccinations at 122300ppm (12.2%) with 3.7% vaccinated

Chile detections at 72973ppm (7.3%)
Detection rate is 376ppm/day and rising.
Fatalities are 1537ppm at 5.7ppm/day.
FR is 2.2% from a 68440ppm detection recorded 14 days previously.
Chile test rate is 2870ppm/day.
12.4% of current tests are positive.
Vaccinations at 965900ppm (96.6%) with 41.6% vaccinated.

Argentina detections at 85233ppm (8.5%)
Detection rate is 727ppm/day and rising to levels previously unseen.
Fatalities are 1755ppm at 11.8ppm/day.
FR is 2.2% from a 81052ppm detection recorded 7 days previously.
Argentina test rate is 930ppm/day.
Test positivity values are impractical.
Vaccinations at 283200ppm (28.3%) with 6.4% vaccinated.

Mexico detections at 18800ppm (1.9%)
Detection rate is 24ppm/day and leveling below 30ppm/day.
Fatalities are 1770ppm at 6.6ppm/day.
FR is 9.5% from a 18659ppm detection recorded 7 days previously.
Mexico test rate is 70ppm/day.
Test positivity values are impractical.
Vaccinations at 246700ppm (24.7%) with 10.0% vaccinated.

South Africa detections at 28145ppm (2.8%)
Detection rate is 57ppm/day and possibly leveling below 60ppm/day.
Fatalities are 954ppm at 1.3ppm/day.
FR is 3.4% from a 27820ppm detection recorded 7 days previously.
SA test rate is 610ppm/day.
9.3% of current tests are positive.
Vaccinations at 18800ppm (1.9%) with 0.8% vaccinated.

Czech detections at 155221ppm (15.5%)
Detection rate is 38ppm/day and falling.
Fatalities are 2813ppm at 1.0ppm/day.
FR is 1.8% from a 155008ppm detection recorded 7 days previously.
Czech test rate is 15990ppm/day.
0.3% of current tests are positive.
Vaccinations at 517400ppm (51.7%) with 14.9% vaccinated.

India detections at 20610ppm (2.1%)
Detection rate is 111ppm/day and falling.
Fatalities at 245ppm at 2.4ppm/day.
FR is 1.2% from a 19968ppm detection recorded 7 days previously.
India test rate 1480ppm/day.
7.5% of current tests are positive.
Vaccinations at 156300ppm (15.6%) with 3.2% vaccinated.

Israel detections at 96992ppm (9.7%)
Detection rate is 2ppm/day and leveling below 10ppm/day
Fatalities at 741ppm at 0.2ppm/day.
FR is 0.8% from a 96981ppm detection recorded 7 days previously.
Israel test rate is 3060ppm/day.
0.1% of current tests are positive
Vaccinations at 1223300ppm (122%) with 59.3% vaccinated.

>
> Chile participated in Phase 3 trials for AstraZeneca,
> Johnson & Johnson, Sinovac and CanSino. Chile has contracts
> with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
> Sinovac is their regular supplier of seasonal flu vaccine.
> Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
> temperatures. About 60% of Chile's contracted 80 million doses
> are from Sinovac.
>
> Chile maintains a Public Health service database that includes
> regular vaccination scheduling. Using these resources alone
> allowed vaccination rates as high as 1 million doses per week
> to be delivered as early as mid-February. Approval of vaccine
> use was based on published Phase 1 and Phase 2 reporting.
>
> multiply ppm by population (in millions) for real numbers.
> China - 1397 million
> Iceland - 0.36 million
> US - 330 million
> Canada - 37 million
> Italy - 60 million
> Sweden - 10 million
> UK - 66 million
> Brazil - 210 million
> Peru - 32 million
> Chile - 19 million
> Argentina - 45 million
> Mexico - 127 million
> South Africa - 58 million
> Czech Republic - 10.7 million
> Israel - 10 million
> India - 1391 million

RL

On 6/3/2021 4:52 PM, legg wrote:
>> A 100ppm daily detection rate would, in one year, result in
>> an approximately 4% penetration within the population.
>>
>> Testing of blood donor samples in Quebec suggests that covid-19
>> antibodies are present in the local population at 3x positive
>> virus detection test rate.
>>
>> Median age in Germany and Italy is 45-46yrs.
>> Median age in Canada, UK and Sweden is 40-41yrs.
>> Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively.
>> Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
>> Median age in Israel is 30.4yrs.
>> Median age in Peru and Mexico is 27.5yrs.
>> Median age in India is 26.8yrs.
>> Median age in South Africa is 25yrs.

> Flu Season? Fatality comparison in the U.S.A.
> http://ve3ute.ca/query/flu_season_021.jpg
> Updated May31

So glad to see "it's just like another flu!" (not)

> The US, UK and Chile have all issued >85% of vaccine doses, with
> vaccination rates of 39%, 35% and 41% respectively. Detection
> and fatality rates, however, do not correlate:
> - The UK has achieved detection and fatality rates comparable to
> those of Israel, which benefits from 2x their vaccination levels.

Am I misreading something? It seems like the fatality rate in UK is
considerably HIGHER than in Israel *and* the US.
UK 2.9%
US 1.8%
IL 0.8%
Are you (they?) using "fatality rate" in two different ways (fatalities
per unit of population vs. fatalities per detected infection)?

> - The US has only achieved detection and fatalty rates comparable
> to the EEC, which benefits from < 1/3 of their vaccination levels.
> - Chile seems to have benefited only in that it's fatality rates
> are reduced from those of its unvaccinated neighbours, Peru and
> Argentina. Detection rates in Chile have risen consistently for
> the last 3 weeks.
>
> - and what the hell is going on in Argentina, anyways?
>

Also, it seems like the nominal ~2% fatality rate is reasonably consistent
(throughout the pandemic) -- except for some FAR outliers. E.g., MX at 9.5%.
Is this possibly due to underreporting of infections due to lack of testing?
(24ppm/day)

> As of Jun 03:
>
> US detections are at 100626ppm.(10.0%)
> FR is 1.8% from a 100365ppm detection recorded 7 days previously.
>
> Canada detections at 36913ppm (3.7%) ~ 195 days behind the US.
> FR is 1.9% from a 36537ppm detection recorded 7 days previously.
>
> Italy detections at 69849ppm. (7.0%)
> FR is 3.0% from a 69564ppm detection recorded 7 days previously.
>
> Sweden detections are unreported (~10.6%)
> no fatality rate can be calculated.
>
> UK detections at 66444ppm. (6.6%)
> FR is 2.9% from a 66134ppm detection recorded 7 days previously.
>
> Brazil detections at 78661ppm. (7.9%)
> FR is 2.9% from a 76883ppm detection recorded 7 days previously.
>
> Peru detections at 59609ppm (6.0%)
> FR is 3.6% from a 58900ppm detection recorded 7 days previously.
>
> Chile detections at 72973ppm (7.3%)
> FR is 2.2% from a 68440ppm detection recorded 14 days previously.
>
> Argentina detections at 85233ppm (8.5%)
> FR is 2.2% from a 81052ppm detection recorded 7 days previously.
>
> Mexico detections at 18800ppm (1.9%)
> FR is 9.5% from a 18659ppm detection recorded 7 days previously.
>
> South Africa detections at 28145ppm (2.8%)
> FR is 3.4% from a 27820ppm detection recorded 7 days previously.
>
> Czech detections at 155221ppm (15.5%)
> FR is 1.8% from a 155008ppm detection recorded 7 days previously.
>
> India detections at 20610ppm (2.1%)
> FR is 1.2% from a 19968ppm detection recorded 7 days previously.
>
> Israel detections at 96992ppm (9.7%)
> FR is 0.8% from a 96981ppm detection recorded 7 days previously.

On Thu, 3 Jun 2021 17:25:26 -0700, Don Y <blockedofcourse@foo.invalid>
wrote:

<snip>
>
>> The US, UK and Chile have all issued >85% of vaccine doses, with
>> vaccination rates of 39%, 35% and 41% respectively. Detection
>> and fatality rates, however, do not correlate:
>> - The UK has achieved detection and fatality rates comparable to
>> those of Israel, which benefits from 2x their vaccination levels.
>
>Am I misreading something? It seems like the fatality rate in UK is
>considerably HIGHER than in Israel *and* the US.
> UK 2.9%
> US 1.8%
> IL 0.8%
>Are you (they?) using "fatality rate" in two different ways (fatalities
>per unit of population vs. fatalities per detected infection)?

I'm refering to daily fatalities, sorry for any confusion.

US 1.6ppm/day
UK 0.1ppm/day
Ch 5.7ppm/day
Il 0.2ppm/day

Daily fatalities tend to follow detection trends by a week or
two.

Fatality rates are, of course, longer term calculations that
don't reflect ongoing trends. They should probably be limited
to 12 month or other specific time periods.

>
>> - The US has only achieved detection and fatalty rates comparable
>> to the EEC, which benefits from < 1/3 of their vaccination levels.
>> - Chile seems to have benefited only in that it's fatality rates
>> are reduced from those of its unvaccinated neighbours, Peru and
>> Argentina. Detection rates in Chile have risen consistently for
>> the last 3 weeks.
>>

RL

> Per capita comparisons are interesting, as they represent
> efforts, within political boundaries, equally.
> Data is easily obtained by visiting the data explorer page
> at Our World in Data:

> http://tiny.cc/ul41tz

>
> A 100ppm daily detection rate would, in one year, result in
> an approximately 4% penetration within the population.
>
> Testing of blood donor samples in Quebec suggests that covid-19
> antibodies are present in the local population at 3x positive
> virus detection test rate.
>
> Median age in Germany and Italy is 45-46yrs.
> Median age in Canada, UK and Sweden is 40-41yrs.
> Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively.
> Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
> Median age in Israel is 30.4yrs.
> Median age in Peru and Mexico is 27.5yrs.
> Median age in India is 26.8yrs.
> Median age in South Africa is 25yrs.
>
>
Comparison charts, as of May31 are available:
http://ve3ute.ca/query/210531_cases_ppm_major.jpg
http://ve3ute.ca/query/210531_cases_ppm_report_group.jpg
http://ve3ute.ca/query/210531_deaths_daily_ppm_report_group.jpg
http://ve3ute.ca/query/210531_deaths_ppm_report_group.jpg
http://ve3ute.ca/query/210531_vaccine_doses_report_group.jpg
http://ve3ute.ca/query/210531_vaccinations_completed_report_group.jpg
>
>
>
Flu Season? Fatality comparison in the U.S.A.
http://ve3ute.ca/query/flu_season_021.jpg
Updated May31
>

> Israel, with >120% of vaccine doses applied to vaccinate 59% of
> the population, reports a daily virus detection rate below 10ppm
> and a 0.2ppm/day fatality rate. These figures have not altered
> significantly in the last 30 days - indicating the end of
> Pfizer's vaccination trial.

The US, UK and Chile have all issued >85% of vaccine doses, with
vaccination rates of 41%, 41% and 44% respectively. Detection
and fatality rates, however, do not correlate:
- The UK has achieved detection and fatality rates comparable to
those of Israel, which benefits from 2x their vaccination levels.
- The US has only achieved detection and fatalty rates comparable
to the EEC, which benefits from < 1/3 of their vaccination levels.
- Chile seems to have benefited only in that it's fatality rates
are reduced from those of its unvaccinated neighbours, Peru and
Argentina. Detection rates in Chile have risen consistently for
the last 3 weeks.

- . . . and what the hell is going on in Argentina, anyways?

- Peru has recently doubled it's covid fatality count. Can only
hope that it's some kind of typo.

As of Jun 07:
US detections are at 100793ppm.(10.1%)
Detection rate is 44ppm/day and possibly leveling below 50ppm/day.
Fatalities are 1806ppm at 1.3ppm/day
FR is 1.8% from a 100488ppm detection recorded 7 days previously.
US test rate is 1660ppm/day
2.7% of current tests are positive.
Vaccinations at 901900ppm (90.2%) with 41.3% fully vaccinated.

Canada detections at 37096ppm (3.7%) ~ 197 days behind the US.
Detection rate at 52ppm/day and falling.
Fatalities are 681ppm at 0.8ppm/day.
FR is 1.9% from a 36732ppm detection recorded 7 days previously.
Canada test rate is 2150ppm/day
2.4% of current tests are positive.
Vaccinations at 691400ppm (69.1%) with 7.2% fully vaccinated.

Italy detections at 69849ppm. (7.0%)
Detection rate is 51ppm/day and falling.
Fatalities are 2089ppm at 1.6ppm/day.
FR is 3.0% from a 70002ppm detection recorded 7 days previously.
Italy test rate is 3400ppm/day.
1.5% of current tests are positive.
Vaccinations at 631500ppm (63.2%) with 21.4% fully vaccinated.

Sweden detections at 106747ppm (~10.7%)
Detection rate is 136ppm/day and falling.
Fatalities are 1438ppm at 1.0ppm/day.
FR is 1.4% from a 105797ppm detection recorded 7 days previously.
Sweden test rate is 3380ppm/day.
4.0% of current tests are positive.
Vaccinations at 549800ppm (55.0%) with 16.8% vaccinated.

UK detections at 66771ppm. (6.7%)
Detection rate is 69ppm/day and rising.
Fatalities are 1887ppm at 0.1ppm/day.
FR is 2.8% from a 66287ppm detection recorded 7 days previously.
UK test rate is 11210ppm/day.
0.6% of current tests are positive.
Vaccinations at 101600ppm (101.6%) with 40.8% vaccinated

Brazil detections at 79724ppm. (8.0%)
Detection rate is 290ppm/day and possibly leveling below 300ppm/day.
Fatalities are 2227ppm at 7.7ppm/day.
FR is 2.9% from a 77696ppm detection recorded 7 days previously.
Brazil test rate is unreported.
No test positivity rate is possible.
Vaccinations at 337300ppm (33.7%) with 10.8% vaccinated.

Peru detections at 60063ppm (6.0%)
Detection rate is 142ppm/day and rising.
Fatalities are reported at 5643ppm - more than double previous
reports at 6.5ppm/day.
FR is therefore 9.6% from a 59067ppm detection recorded 7 days
previously.
Peru tests performed are unreported.
No test positivity rate is possible.
Vaccinations at 130400ppm (13.0%) with 4.0% vaccinated

Chile detections at 74699ppm (7.5%)
Detection rate is 377ppm/day and possibly leveling below 390ppm/day.
Fatalities are 1566ppm at 5.1ppm/day.
FR is 2.3% from a 69570ppm detection recorded 14 days previously.
Chile test rate is 3380ppm/day.
11.2% of current tests are positive.
Vaccinations at 1018100ppm (101.8%) with 44.0% vaccinated.

Argentina detections at 87518ppm (8.8%)
Detection rate is 638ppm/day and possibly leveling below 650ppm/day.
Fatalities are 1797ppm at 11.9ppm/day.
FR is 2.2% from a 83052ppm detection recorded 7 days previously.
Argentina test rate is 810ppm/day.
Test positivity values are impractical.
Vaccinations at 311800ppm (31.2%) with 6.6% vaccinated.

Mexico detections at 18876ppm (1.9%)
Detection rate is 23ppm/day and leveling below 30ppm/day.
Fatalities are 1775ppm at 5.9ppm/day.
FR is 9.5% from a 18714ppm detection recorded 7 days previously.
Mexico test rate is 70ppm/day.
Test positivity values are impractical.
Vaccinations at 267300ppm (24.7%) with 11.0% vaccinated.

South Africa detections at 28606ppm (2.9%)
Detection rate is 90ppm/day and rising.
Fatalities are 961ppm at 1.5ppm/day.
FR is 3.4% from a 27973ppm detection recorded 7 days previously.
SA test rate is 630ppm/day.
14.3% of current tests are positive.
Vaccinations at 22700ppm (2.3%) with no fully vaccinated reported.

Czech detections at 155338ppm (15.5%)
Detection rate is 31ppm/day and falling.
Fatalities are 2816ppm at 0.7ppm/day.
FR is 1.8% from a 155118ppm detection recorded 7 days previously.
Czech test rate is 15240ppm/day.
0.2% of current tests are positive.
Vaccinations at 54800ppm (54.8%) with 16.1% vaccinated.

India detections at 20949ppm (2.1%)
Detection rate is 89ppm/day and falling.
Fatalities at 253ppm at 2.1ppm/day.
FR is 1.2% from a 20324ppm detection recorded 7 days previously.
India test rate 1740ppm/day.
5.1% of current tests are positive.
Vaccinations at 165200ppm (16.5%) with 3.2% vaccinated.

Israel detections at 96998ppm (9.7%)
Detection rate is 2ppm/day and leveling below 10ppm/day
Fatalities at 741ppm at 0.1ppm/day.
FR is 0.8% from a 96985ppm detection recorded 7 days previously.
Israel test rate is 2600ppm/day.
0.1% of current tests are positive
Vaccinations at 1224500ppm (122%) with 59.4% vaccinated.

>
> Chile participated in Phase 3 trials for AstraZeneca,
> Johnson & Johnson, Sinovac and CanSino. Chile has contracts
> with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
> Sinovac is their regular supplier of seasonal flu vaccine.
> Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
> temperatures. About 60% of Chile's contracted 80 million doses
> are from Sinovac.
>
> Chile maintains a Public Health service database that includes
> regular vaccination scheduling. Using these resources alone
> allowed vaccination rates as high as 1 million doses per week
> to be delivered as early as mid-February. Approval of vaccine
> use was based on published Phase 1 and Phase 2 reporting.
>
> multiply ppm by population (in millions) for real numbers.
> China - 1397 million
> Iceland - 0.36 million
> US - 330 million
> Canada - 37 million
> Italy - 60 million
> Sweden - 10 million
> UK - 66 million
> Brazil - 210 million
> Peru - 32 million
> Chile - 19 million
> Argentina - 45 million
> Mexico - 127 million
> South Africa - 58 million
> Czech Republic - 10.7 million
> Israel - 10 million
> India - 1391 million

RL

> Per capita comparisons are interesting, as they represent
> efforts, within political boundaries, equally.
> Data is easily obtained by visiting the data explorer page
> at Our World in Data:

> http://tiny.cc/ul41tz

>
> A 100ppm daily detection rate would, in one year, result in
> an approximately 4% penetration within the population.
>
> Testing of blood donor samples in Quebec suggests that covid-19
> antibodies are present in the local population at 3x positive
> virus detection test rate.
>
> Median age in Germany and Italy is 45-46yrs.
> Median age in Canada, UK and Sweden is 40-41yrs.
> Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively.
> Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
> Median age in Israel is 30.4yrs.
> Median age in Peru and Mexico is 27.5yrs.
> Median age in India is 26.8yrs.
> Median age in South Africa is 25yrs.
>
>
> Comparison charts, as of May31 are available:
> http://ve3ute.ca/query/210531_cases_ppm_major.jpg
> http://ve3ute.ca/query/210531_cases_ppm_report_group.jpg
> http://ve3ute.ca/query/210531_deaths_daily_ppm_report_group.jpg
> http://ve3ute.ca/query/210531_deaths_ppm_report_group.jpg
> http://ve3ute.ca/query/210531_vaccine_doses_report_group.jpg
> http://ve3ute.ca/query/210531_vaccinations_completed_report_group.jpg
>
>
>
> Flu Season? Fatality comparison in the U.S.A.
> http://ve3ute.ca/query/flu_season_021.jpg
> Updated May31
>

> Israel, with >120% of vaccine doses applied to vaccinate 59% of
> the population, reports a daily virus detection rate below 10ppm
> and a 0.2ppm/day fatality rate. These figures have not altered
> significantly in the last 30 days - indicating the end of
> Pfizer's vaccination trial.

The US, UK and Chile have all issued >85% of vaccine doses, with
vaccination rates of 42%, 42% and 45% respectively. Detection
and fatality rates, however, do not correlate:
- The UK has achieved detection and fatality rates comparable to
those of Israel, which benefits from 2x their vaccination levels.
- The US has only achieved detection and fatalty rates comparable
to the EEC, which benefits from < 1/3 of their vaccination levels.
- Chile seems to have benefited only in that it's fatality rates
are reduced from those of its unvaccinated neighbours, Peru and
Argentina. Detection rates in Chile have risen consistently for
the last 3 weeks.

- . . . and what the hell is going on in Argentina, anyways?

- Peru has recently doubled it's covid fatality count. It's not
a typo, but a correction in record keeping.

As of Jun 10:
US detections are at 100948ppm.(10.1%)
Detection rate is 46ppm/day and possibly leveling below 50ppm/day.
Fatalities are 1808ppm at 1.2ppm/day
FR is 1.8% from a 100683ppm detection recorded 7 days previously.
US test rate is 1570ppm/day
2.9% of current tests are positive.
Vaccinations at 911100ppm (91.1%) with 42.0% fully vaccinated.

Canada detections at 37212ppm (3.7%) ~ 200 days behind the US.
Detection rate at 43ppm/day and falling.
Fatalities are 683ppm at 0.9ppm/day.
FR is 1.9% from a 36970ppm detection recorded 7 days previously.
Canada test rate is 2000ppm/day
2.2% of current tests are positive.
Vaccinations at 722200ppm (72.2%) with 8.4% fully vaccinated.

Italy detections at 70090ppm. (7.0%)
Detection rate is 34ppm/day and falling.
Fatalities are 2094ppm at 1.1ppm/day.
FR is 3.0% from a 69882ppm detection recorded 7 days previously.
Italy test rate is 2930ppm/day.
1.2% of current tests are positive.
Vaccinations at 659800ppm (66.0%) with 22.1% fully vaccinated.

Sweden detections at 107126ppm (~10.7%)
Detection rate is 190ppm/day and rising.
Fatalities are 1440ppm at 1.0ppm/day.
FR is 1.4% from a 106641ppm detection recorded 7 days previously.
Sweden test rate is 3250ppm/day.
5.8% of current tests are positive.
Vaccinations at 583000ppm (58.3%) with 18.5% vaccinated.

UK detections at 67049ppm. (6.7%)
Detection rate is 86ppm/day and rising.
Fatalities are 1887ppm at 0.1ppm/day.
FR is 2.8% from a 66520ppm detection recorded 7 days previously.
UK test rate is 12090ppm/day.
0.7% of current tests are positive.
Vaccinations at 1020100ppm (102.0%) with 42.0% vaccinated

Brazil detections at 80556ppm. (8.1%)
Detection rate is 271ppm/day and possibly leveling below 290ppm/day.
Fatalities are 2243ppm at 7.9ppm/day.
FR is 2.8% from a 79053ppm detection recorded 7 days previously.
Brazil test rate is unreported.
No test positivity rate is possible.
Vaccinations at 352000ppm (35.2%) with 10.8% vaccinated.

Peru detections at 60292ppm (6.0%)
Detection rate is 97ppm/day and possibly leveling below 150ppm/day.
Fatalities are reported at 5664ppm at 9.6ppm/day.
FR is 9.6% from a 59609ppm detection recorded 7 days previously.
Peru test rate is unreported.
No test positivity rate is possible.
Vaccinations at 138700ppm (13.9%) with 4.4% vaccinated

Chile detections at 75630ppm (7.6%)
Detection rate is 380ppm/day and possibly leveling below 390ppm/day.
Fatalities are 1575ppm at 5.1ppm/day.
FR is 2.3% from a 76363ppm detection recorded 14 days previously.
Chile test rate is 3430ppm/day.
11.0% of current tests are positive.
Vaccinations at 1037300ppm (103.7%) with 45.4% vaccinated.

Argentina detections at 89356ppm (8.9%)
Detection rate is 589ppm/day and falling.
Fatalities are 1829ppm at 12.5ppm/day.
FR is 2.1% from a 85947ppm detection recorded 7 days previously.
Argentina test rate is 870ppm/day.
Test positivity values are impractical.
Vaccinations at 332300ppm (33.2%) with 6.8% vaccinated.

Mexico detections at 18939ppm (1.9%)
Detection rate is 20ppm/day and leveling below 30ppm/day.
Fatalities are 1777ppm at 1.3ppm/day.
FR is 9.4% from a 18822ppm detection recorded 7 days previously.
Mexico test rate is 70ppm/day.
Test positivity values are impractical.
Vaccinations at 272700ppm (27.3%) with 11.1% vaccinated.

South Africa detections at 28882ppm (2.9%)
Detection rate is 91ppm/day and rising.
Fatalities are 964ppm at 1.4ppm/day.
FR is 3.4% from a 28333ppm detection recorded 7 days previously.
SA test rate is 650ppm/day.
14.0% of current tests are positive.
Vaccinations at 25700ppm (2.6%) with no full vaccinations reported.

Czech detections at 155419ppm (15.5%)
Detection rate is 28ppm/day and falling.
Fatalities are 2819ppm at 1.0ppm/day.
FR is 1.8% from a 155255ppm detection recorded 7 days previously.
Czech test rate is 14300ppm/day.
0.2% of current tests are positive.
Vaccinations at 57680ppm (57.7%) with 17.3% vaccinated.

India detections at 21147ppm (2.1%)
Detection rate is 77ppm/day and falling.
Fatalities at 256ppm at 1.8ppm/day.
FR is 1.2% from a 20766ppm detection recorded 7 days previously.
India test rate 2230ppm/day.
3.5% of current tests are positive.
Vaccinations at 171600ppm (17.2%) with 3.3% vaccinated.

Israel detections at 97060ppm (9.7%)
Detection rate is 1ppm/day and leveling below 10ppm/day
Fatalities at 741ppm at 0.1ppm/day.
FR is 0.8% from a 96994ppm detection recorded 7 days previously.
Israel test rate is 2040ppm/day.
0.0% of current tests are positive
Vaccinations at 1226200ppm (123%) with 59.4% vaccinated.

>
> Chile participated in Phase 3 trials for AstraZeneca,
> Johnson & Johnson, Sinovac and CanSino. Chile has contracts
> with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
> Sinovac is their regular supplier of seasonal flu vaccine.
> Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
> temperatures. About 60% of Chile's contracted 80 million doses
> are from Sinovac.
>
> Chile maintains a Public Health service database that includes
> regular vaccination scheduling. Using these resources alone
> allowed vaccination rates as high as 1 million doses per week
> to be delivered as early as mid-February. Approval of vaccine
> use was based on published Phase 1 and Phase 2 reporting.
>
> multiply ppm by population (in millions) for real numbers.
> China - 1397 million
> Iceland - 0.36 million
> US - 330 million
> Canada - 37 million
> Italy - 60 million
> Sweden - 10 million
> UK - 66 million
> Brazil - 210 million
> Peru - 32 million
> Chile - 19 million
> Argentina - 45 million
> Mexico - 127 million
> South Africa - 58 million
> Czech Republic - 10.7 million
> Israel - 10 million
> India - 1391 million

RL

> Per capita comparisons are interesting, as they represent
> efforts, within political boundaries, equally.
> Data is easily obtained by visiting the data explorer page
> at Our World in Data:

> http://tiny.cc/ul41tz

>
> A 100ppm daily detection rate would, in one year, result in
> an approximately 4% penetration within the population.
>
> Testing of blood donor samples in Quebec suggests that covid-19
> antibodies are present in the local population at 3x positive
> virus detection test rate.
>
> Median age in Germany and Italy is 45-46yrs.
> Median age in Canada, UK and Sweden is 40-41yrs.
> Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively.
> Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
> Median age in Israel is 30.4yrs.
> Median age in Peru and Mexico is 27.5yrs.
> Median age in India is 26.8yrs.
> Median age in South Africa is 25yrs.
>
>
> Comparison charts, as of May31 are available:
> http://ve3ute.ca/query/210531_cases_ppm_major.jpg
> http://ve3ute.ca/query/210531_cases_ppm_report_group.jpg
> http://ve3ute.ca/query/210531_deaths_daily_ppm_report_group.jpg
> http://ve3ute.ca/query/210531_deaths_ppm_report_group.jpg
> http://ve3ute.ca/query/210531_vaccine_doses_report_group.jpg
> http://ve3ute.ca/query/210531_vaccinations_completed_report_group.jpg
>
>
>
> Flu Season? Fatality comparison in the U.S.A.
> http://ve3ute.ca/query/flu_season_021.jpg
> Updated May31
>

> Israel, with >120% of vaccine doses applied to vaccinate 59% of
> the population, reports a daily virus detection rate below 10ppm
> and a 0.2ppm/day fatality rate. These figures have not altered
> significantly in the last 30 days - indicating the end of
> Pfizer's vaccination trial.

The US, UK and Chile have all issued >92% of vaccine doses, with
vaccination rates of 43%, 44% and 47% respectively. Detection
and fatality rates, however, do not correlate:
- The UK had achieved detection and fatality rates comparable to
those of Israel, which benefits from 2x their vaccination levels,
- The US has only achieved detection and fatalty rates comparable
to the EEC, which benefits from < 1/2 of their vaccination levels.
- Chile seems to have benefited only in that it's fatality rates
are reduced from those of its unvaccinated neighbours, Peru and
Argentina. Detection rates in Chile have risen consistently for
the last 4 weeks.

- . . . and what the hell is going on in Argentina, anyways?

- Peru has recently doubled it's covid fatality count. It's not
a typo, but a correction in record keeping.

As of Jun 14:
US detections are at 101093ppm.(10.1%)
Detection rate is 43ppm/day and possibly leveling below 50ppm/day.
Fatalities are 1812ppm at 1.1ppm/day
FR is 1.8% from a 100839ppm detection recorded 7 days previously.
US test rate is 1790ppm/day
2.4% of current tests are positive.
Vaccinations at 924900ppm (92.5%) with 43.0% fully vaccinated.

Canada detections at 37345ppm (3.7%) ~ 204 days behind the US.
Detection rate at 36ppm/day and falling.
Fatalities are 686ppm at 0.8ppm/day.
FR is 1.8% from a 37144ppm detection recorded 7 days previously.
Canada test rate is 1900ppm/day
1.9% of current tests are positive.
Vaccinations at 769000ppm (76.9%) with 12.2% fully vaccinated.

Italy detections at 70207ppm. (7.0%)
Detection rate is 29ppm/day and falling.
Fatalities are 2101ppm at 1.1ppm/day.
FR is 3.0% from a 70023ppm detection recorded 7 days previously.
Italy test rate is 3160ppm/day.
0.9% of current tests are positive.
Vaccinations at 698700ppm (69.9%) with 23.3% fully vaccinated.

Sweden detections at 107281ppm (10.7%)
Detection rate is 76ppm/day and possibly leveling below 100ppm/day.
Fatalities are 1443ppm at 0.7ppm/day.
FR is 1.3% from a 107281ppm detection recorded 7 days previously.
Sweden test rate is 3010ppm/day.
2.5% of current tests are positive.
Vaccinations at 609100ppm (60.9%) with 20.5% vaccinated.

UK detections at 67492ppm. (6.7%)
Detection rate is 103ppm/day and rising.
Fatalities are 1888ppm at 0.1ppm/day.
FR is 2.8% from a 66853ppm detection recorded 7 days previously.
UK test rate is 13480ppm/day.
0.8% of current tests are positive.
Vaccinations at 1036900ppm (103.7%) with 43.9% vaccinated

Brazil detections at 81920ppm. (8.2%)
Detection rate is 313ppm/day and rising.
Fatalities are 2293ppm at 9.4ppm/day.
FR is 2.9% from a 79903ppm detection recorded 7 days previously.
Brazil test rate is unreported.
No test positivity rate is possible.
Vaccinations at 367600ppm (36.8%) with 11.1% vaccinated.

Peru detections at 60768ppm (6.1%)
Detection rate is 101ppm/day and possibly leveling below 130ppm/day.
Fatalities are reported at 5723ppm at 11.4ppm/day.
FR is 9.5% from a 60160ppm detection recorded 7 days previously.
Peru test rate is unreported.
No test positivity rate is possible.
Vaccinations at 158000ppm (15.8%) with 5.6% vaccinated

Chile detections at 77237ppm (7.7%)
Detection rate is 363ppm/day and possibly leveling below 390ppm/day.
Fatalities are 1606ppm at 5.8ppm/day.
FR is 2.2% from a 72417ppm detection recorded 14 days previously.
Chile test rate is 3460ppm/day.
10.5% of current tests are positive.
Vaccinations at 1067400ppm (107.7%) with 47.0% vaccinated.

Argentina detections at 91252ppm (9.2%)
Detection rate is 533ppm/day and falling.
Fatalities are 1888ppm at 13.1ppm/day.
FR is 2.1% from a 88009ppm detection recorded 7 days previously.
Argentina test rate is 880ppm/day.
Test positivity values are impractical.
Vaccinations at 360400ppm (36.0%) with 7.3% vaccinated.

Mexico detections at 19035ppm (1.9%)
Detection rate is 23ppm/day and level below 30ppm/day.
Fatalities are 1785ppm at 1.5ppm/day.
FR is 9.5% from a 18882ppm detection recorded 7 days previously.
Mexico test rate is 70ppm/day.
Test positivity values are impractical.
Vaccinations at 286800ppm (28.7%) with 11.6% vaccinated.

South Africa detections at 29457ppm (2.9%)
Detection rate is 122ppm/day and rising.
Fatalities are 974ppm at 1.9ppm/day.
FR is 3.4% from a 28661ppm detection recorded 7 days previously.
SA test rate is 690ppm/day.
17.7% of current tests are positive.
Vaccinations at 29900ppm (3.0%) with no full vaccinations reported.

Czech detections at 155486ppm (15.5%)
Detection rate is 21ppm/day and falling.
Fatalities are 2822ppm at 0.9ppm/day.
FR is 1.8% from a 155347ppm detection recorded 7 days previously.
Czech test rate is 13120ppm/day.
0.2% of current tests are positive.
Vaccinations at 611000ppm (61.1%) with 19.5% vaccinated.

India detections at 21384ppm (2.1%)
Detection rate is 62ppm/day and falling.
Fatalities at 271ppm at 2.6ppm/day.
FR is 1.3% from a 21012ppm detection recorded 7 days previously.
India test rate 1740ppm/day.
3.6% of current tests are positive.
Vaccinations at 180700ppm (18.1%) with 3.4% vaccinated.

Israel detections at 97009ppm (9.7%)
Detection rate is 2ppm/day and leveling below 10ppm/day
Fatalities at 743ppm at 0.2ppm/day.
FR is 0.8% from a 97000ppm detection recorded 7 days previously.
Israel test rate is 2120ppm/day.
0.1% of current tests are positive
Vaccinations at 1227400ppm (123%) with 59.4% vaccinated.

>
> Chile participated in Phase 3 trials for AstraZeneca,
> Johnson & Johnson, Sinovac and CanSino. Chile has contracts
> with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
> Sinovac is their regular supplier of seasonal flu vaccine.
> Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
> temperatures. About 60% of Chile's contracted 80 million doses
> are from Sinovac.
>
> Chile maintains a Public Health service database that includes
> regular vaccination scheduling. Using these resources alone
> allowed vaccination rates as high as 1 million doses per week
> to be delivered as early as mid-February. Approval of vaccine
> use was based on published Phase 1 and Phase 2 reporting.
>
> multiply ppm by population (in millions) for real numbers.
> China - 1397 million
> Iceland - 0.36 million
> US - 330 million
> Canada - 37 million
> Italy - 60 million
> Sweden - 10 million
> UK - 66 million
> Brazil - 210 million
> Peru - 32 million
> Chile - 19 million
> Argentina - 45 million
> Mexico - 127 million
> South Africa - 58 million
> Czech Republic - 10.7 million
> Israel - 10 million
> India - 1391 million

RL